Vlado Perkovic

Dean

Vlado Perkovic is Dean of Medicine and Scientia Professor at UNSW, a Professorial Fellow at The George Institute, Australia, and a Staff Specialist in Nephrology at the Royal North Shore Hospital. His research focus is in clinical trials and epidemiology, in particular in preventing the progression of kidney disease and its complications. He leads several major international clinical trials, and serves on the Steering Committees of several others. He has been involved in developing Australian and global guidelines in kidney disease, cardiovascular risk assessment and blood pressure management.

 

Vlado holds a Doctor of Philosophy from the University of Melbourne and completed his undergraduate training at The Royal Melbourne Hospital. He is Chair of the International Society of Nephrology Action for Clinical Trials (ISN-ACT) group; and is a Fellow of the Royal Australasian College of Physicians, of the Australian Academy of Health and Medical Sciences and of the American Society of Nephrology

 

 

PUBLICATIONS

Conference Papers
add
Levey AS; Gansevoort RT; Coresh J; Inker LA; Heerspink HL; Grams ME; Greene T; Tighiouart H; Matsushita K; Ballew SH; Sang Y; Vonesh E; Ying J; Manley T; de Zeeuw D; Eckardt KU; Levin A; Perkovic V; Zhang L; Willis K, 2020, 'Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency', in American Journal of Kidney Diseases, pp. 84 - 104, http://dx.doi.org/10.1053/j.ajkd.2019.06.009
2020
Baigent C; Herrington WG; Coresh J; Landray MJ; Levin A; Perkovic V; Pfeffer MA; Rossing P; Walsh M; Wanner C; Wheeler DC; Winkelmayer WC; McMurray JJV; Abu-Alfa A; Archdeacon P; Block GA; Caskey FJ; Cheung AK; Cooper B; Craig JC; Dember LM; Eknoyan G; Gansevoort RT; Gill JS; Gillespie B; Greene T; Harris DC; Haynes R; Hemmelgarn BR; Herzog CA; Hiemstra TF; Inker LA; Jardine MJ; Jha V; Jiang L; Johansen KL; Kewalramani R; Lambers Heerspink HJ; Lefkowitz M; Lok CE; Loud F; Mačiulaitis R; Maddux DW; Maddux FW; Madero M; Mariz S; Mauer M; Nally JV; Nangaku M; Okpechi IG; Parfrey PS; Pecoits-Filho R; Pereira BJG; Rocco MV; Rossignol P; Schaefer F; Tentori F; Thompson A; Tonelli M; Tong A; Toto RD; Tuttle KR; Vetter T; Moon Wang AY; Zannad F, 2016, 'Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference', in Kidney International, Paris, France, pp. 297 - 305, presented at KDIGO Controversies Conference on Challenges in the Conduct of Clinical Trials in Nephrology, Paris, France, 08 September 2016 - 11 September 2016, http://dx.doi.org/10.1016/j.kint.2017.04.019
2016
Kerr P; Perkovic V; Petrie J; Agar J; Disney A, 2005, 'Dialysis adequacy (HD) guidelines: Dose of haemodialysis', in Nephrology, http://dx.doi.org/10.1111/j.1440-1797.2005.00464_1.x
2005
Masterson R; Leikis M; Perkovic V; Nicholls K; Walker R, 2003, 'Sirolimus: A single center experience in combination with calcineurin inhibitors', in Transplantation Proceedings, pp. S99 - S104, http://dx.doi.org/10.1016/S0041-1345(03)00219-7
2003
Journal articles
add
Neuen BL; Jardine MJ; Perkovic V, 2020, 'Sodium-glucose cotransporter 2 inhibition: which patient with chronic kidney disease should be treated in the future?', Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, vol. 35, pp. i48 - i55, http://dx.doi.org/10.1093/ndt/gfz252
2020
Arnott C; Li Q; Kang A; Neuen BL; Bompoint S; Lam CSP; Rodgers A; Mahaffey KW; Cannon CP; Perkovic V; Jardine MJ; Neal B, 2020, 'Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis', Journal of the American Heart Association, vol. 9, pp. e014908, http://dx.doi.org/10.1161/JAHA.119.014908
2020
Neuen BL; Perkovic V, 2020, 'Pilot trials in nephrology: Establishing a base for large-scale randomized trials', Journal of the American Society of Nephrology, vol. 31, pp. 4 - 6, http://dx.doi.org/10.1681/ASN.2019111196
2020
Cannon CP; Perkovic V; Agarwal R; Baldassarre J; Bakris G; Charytan DM; de Zeeuw D; Edwards R; Greene T; Heerspink HJL; Jardine MJ; Levin A; Li JW; Neal B; Pollock C; Wheeler DC; Zhang H; Zinman B; Mahaffey KW, 2020, 'Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: Results From the CREDENCE Trial', Circulation, vol. 141, pp. 407 - 410, http://dx.doi.org/10.1161/CIRCULATIONAHA.119.044359
2020
Li JW; Woodward M; Perkovic V; Figtree GA; Heerspink HJL; Mahaffey KW; de Zeeuw D; Vercruysse F; Shaw W; Matthews DR; Neal B, 2020, 'Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes', JACC: Heart Failure, vol. 8, pp. 57 - 66, http://dx.doi.org/10.1016/j.jchf.2019.08.004
2020
Ha JT; Neuen BL; Cheng LP; Jun M; Toyama T; Gallagher MP; Jardine MJ; Sood MM; Garg AX; Palmer SC; Mark PB; Wheeler DC; Jha V; Freedman B; Johnson DW; Perkovic V; Badve SV, 2019, 'Benefits and harms of oral anticoagulant therapy in chronic kidney disease', Annals of Internal Medicine, vol. 171, pp. 181 - 189, http://dx.doi.org/10.7326/M19-0087
2019
Neuen BL; Young T; Heerspink HJL; Neal B; Perkovic V; Billot L; Mahaffey KW; Charytan DM; Wheeler DC; Arnott C; Bompoint S; Levin A; Jardine MJ, 2019, 'SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis', The Lancet Diabetes and Endocrinology, vol. 7, pp. 845 - 854, http://dx.doi.org/10.1016/S2213-8587(19)30256-6
2019
Ohkuma T; Jun M; Chalmers J; Cooper ME; Hamet P; Harrap S; Zoungas S; Perkovic V; Woodward M, 2019, 'Combination of changes in estimated GFR and albuminuria and the risk of major clinical outcomes', Clinical Journal of the American Society of Nephrology, vol. 14, pp. 862 - 872, http://dx.doi.org/10.2215/CJN.13391118
2019
Ohkuma T; Van Gaal L; Shaw W; Mahaffey KW; de Zeeuw D; Matthews DR; Perkovic V; Neal B, 2019, 'Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program', Diabetes, Obesity and Metabolism, http://dx.doi.org/10.1111/dom.13920
2019
Heerspink HJL; Parving HH; Andress DL; Bakris G; Correa-Rotter R; Hou FF; Kitzman DW; Kohan D; Makino H; McMurray JJV; Melnick JZ; Miller MG; Pergola PE; Perkovic V; Tobe S; Yi T; Wigderson M; de Zeeuw D; Elbert A; Vallejos A; Alvarisqueta A; Maffei L; Juncos L; de Arteaga J; Greloni G; Farias E; Zucchini A; Vogel D; Cusumano A; Santos J; Fraenkel M; Gallagher M; Davis T; Acharya S; Cooke D; Suranyi M; Roger S; Toussaint N; Pollock C; Chan D; Stranks S; MacIsaac R; Endre Z; Schmidt A; Prager R; Mayer G; Warling X; Jadoul M; Hougardy J; Vercammen C; Van Vlem B; Gillard P; Costa e Forti A; Borges JL; Santos Canani L; Eliaschewitz F; Leite S; Fraige Filho F; Paschoalin R; Moura Neto JA; Deboni L; de Lourdes Noronha I; Cercato C; Prompt CA; Zanella M; Rassi N; D'Avila D; Milagres R; Felicio J; Pecoits Filho R; Riella MC; Salles J; Keitel E; Draibe S; Amodeo C; Youmbissi J; Roy L; Cournoyer S; Jolly S; Pichette V; Nesrallah G; Bajaj HS; Khandwala H; Aronson R; Goluch R; Tam P; Rabbat C; Bailey G; Chow S; Castillo A; Danin Vargas A; Gonzalez F; Munoz R; Gutierrez V; Godoy G; Zhao H; Liu Z; Zhao M; Guo X; Su B, 2019, 'Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial', The Lancet, vol. 393, pp. 1937 - 1947, http://dx.doi.org/10.1016/S0140-6736(19)30772-X
2019
Smyth B; Haber A; Trongtrakul K; Hawley C; Perkovic V; Woodward M; Jardine M, 2019, 'Representativeness of Randomized Clinical Trial Cohorts in End-stage Kidney Disease: A Meta-analysis', JAMA Internal Medicine, vol. 179, pp. 1316 - 1324, http://dx.doi.org/10.1001/jamainternmed.2019.1501
2019
Zhou Z; Jardine M; Perkovic V; Matthews DR; Mahaffey KW; de Zeeuw D; Fulcher G; Desai M; Oh R; Simpson R; Watts NB; Neal B, 2019, 'Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program', Diabetologia, vol. 62, pp. 1854 - 1867, http://dx.doi.org/10.1007/s00125-019-4955-5
2019
Li J; Badve SV; Zhou Z; Oh R; Lee M; Perkovic V; De Zeeuw D; Mahaffey KW; Fulcher G; Matthews DR; Neal B, 2019, 'The Effects of Canagliflozin on Uric Acid and Gout in Patients with Type 2 Diabetes in the CANVAS Program', DIABETES, vol. 68, http://dx.doi.org/10.2337/db19-1216-P
2019
Jardine MJ; Mahaffey KW; Perkovic V, 2019, 'Canagliflozin and Renal Outcomes in Diabetic Nephropathy. Reply', The New England journal of medicine, vol. 381, pp. 1089 - 1090, http://dx.doi.org/10.1056/NEJMc1909687
2019
Oshima M; Jun M; Ohkuma T; Toyama T; Wada T; Cooper ME; Hadjadj S; Hamet P; Harrap S; Mancia G; Marre M; Williams B; Chalmers J; Woodward M; Perkovic V, 2019, 'The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study', Diabetologia, vol. 62, pp. 1988 - 1997, http://dx.doi.org/10.1007/s00125-019-4948-4
2019
Inagaki N; Yang W; Watada H; Ji L; Schnaidt S; Pfarr E; Okamura T; Johansen OE; George JT; von Eynatten M; Rosenstock J; Perkovic V; Wanner C; Cooper ME; Alexander JH; Komuro I; Nangaku M, 2019, 'Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA® trial', Diabetology International, http://dx.doi.org/10.1007/s13340-019-00412-x
2019
Neuen BL; Cherney DZ; Jardine MJ; Perkovic V, 2019, 'Sodium-glucose cotransporter inhibitors in type 2 diabetes: Thinking beyond glucose lowering', CMAJ, vol. 191, pp. E1128 - E1135, http://dx.doi.org/10.1503/cmaj.190047
2019
Neuen BL; Ohkuma T; Neal B; Matthews DR; De Zeeuw D; Mahaffey KW; Fulcher G; Li Q; Jardine M; Oh R; Heerspink HL; Perkovic V, 2019, 'Effect of canagliflozin on renal and cardiovascular outcomes across different levels of albuminuria: Data from the CANVAS program', Journal of the American Society of Nephrology, vol. 30, pp. 2229 - 2242, http://dx.doi.org/10.1681/ASN.2019010064
2019
Smyth B; Krishnan AV; Gallagher M; Kiernan M; Snelling P; Hawley C; Fernando M; Hand S; Grimley K; Burman J; Heath A; Kang A; Perkovic V; Jardine MJ, 2019, 'Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocol', BMJ Open, vol. 9, http://dx.doi.org/10.1136/bmjopen-2018-023736
2019
Matthews DR; Li Q; Perkovic V; Mahaffey KW; de Zeeuw D; Fulcher G; Desai M; Hiatt WR; Nehler M; Fabbrini E; Kavalam M; Lee M; Neal B, 2019, 'Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program', Diabetologia, http://dx.doi.org/10.1007/s00125-019-4839-8
2019
Zhou Z; Lindley RI; Rådholm K; Jenkins B; Watson J; Perkovic V; Mahaffey KW; de Zeeuw D; Fulcher G; Shaw W; Oh R; Desai M; Matthews DR; Neal B, 2019, 'Canagliflozin and Stroke in Type 2 Diabetes Mellitus', Stroke, vol. 50, pp. 396 - 404, http://dx.doi.org/10.1161/STROKEAHA.118.023009
2019
Heerspink HJL; Greene T; Tighiouart H; Gansevoort RT; Coresh J; Simon AL; Chan TM; Hou FF; Lewis JB; Locatelli F; Praga M; Schena FP; Levey AS; Inker LA; Sevillano A; Kamper AL; van Zuilen AD; Brenner BM; Maes B; Ihle BU; Barret B; Leung CB; Szeto CC; Fitzner C; Wanner C; Pozzi C; Montagnino CP; Xie D; de Zeeuw D; Lewis E; Verde E; Gutierrez E; Imai E; Caravaca F; Fervenza FC; Kobayashi F; Moroni G; Becker GJ; Beck GJ; Appel GB; Frisch G; van Essen GG; Maschio G; Remuzzi G; Montogrino G; Parving HH; Heerspink HJL; Makino H; Jehan I; Wetzels JFM; Donadio J; Dwyer J; van den Brand J; Kusek J; Lachin JM; Luño J; Lewis JB; Floege J; Abebe KZ; Chow KM; Hunsicker LG; del Vecchio L; Carlo M; Goicoechea M; von Eynatten M; Poulter N; Chaturvedi N; Passerini P; de Jong PE; Blankestijn PJ; Li P; Ruggenenti P; Zucchelli P; Kincaid-Smith PS; Hilgers RD; Estacio RO; Rohde RD; Katafuchi R; Toto RD; Schrier RW; Rodby RA; Perrone RD; Ito S; Klahr S; Andrulli S; Strandgaard S; Hannedouche TP; Rauen T; Verdalles U; Perkovic V; Keane W, 2019, 'Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials', The Lancet Diabetes and Endocrinology, vol. 7, pp. 128 - 139, http://dx.doi.org/10.1016/S2213-8587(18)30314-0
2019
Cheung AK; Chang TI; Cushman WC; Furth SL; Ix JH; Pecoits-Filho R; Perkovic V; Sarnak MJ; Tobe SW; Tomson CRV; Cheung M; Wheeler DC; Winkelmayer WC; Mann JFE; Bakris GL; Damasceno A; Dwyer JP; Fried LF; Haynes R; Hirawa N; Holdaas H; Ibrahim HN; Ingelfinger JR; Iseki K; Khwaja A; Kimmel PL; Kovesdy CP; Ku E; Lerma EV; Luft FC; Lv J; McFadden CB; Muntner P; Myers MG; Navaneethan SD; Parati G; Peixoto AJ; Prasad R; Rahman M; Rocco MV; Rodrigues CIS; Roger SD; Stergiou GS; Tomlinson LA; Tonelli M; Toto RD; Tsukamoto Y; Walker R; Wang AYM; Wang J; Warady BA; Whelton PK; Williamson JD, 2019, 'Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference', Kidney International, vol. 95, pp. 1027 - 1036, http://dx.doi.org/10.1016/j.kint.2018.12.025
2019
Rahimi K; Canoy D; Nazarzadeh M; Salimi-Khorshidi G; Woodward M; Teo K; Davis BR; Chalmers J; Pepine CJ, 2019, 'Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: An overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC)', BMJ Open, vol. 9, pp. e028698, http://dx.doi.org/10.1136/bmjopen-2018-028698
2019
Coresh J; Heerspink HJL; Sang Y; Matsushita K; Arnlov J; Astor BC; Black C; Brunskill NJ; Carrero JJ; Feldman HI; Fox CS; Inker LA; Ishani A; Ito S; Jassal S; Konta T; Polkinghorne K; Romundstad S; Solbu MD; Stempniewicz N; Stengel B; Tonelli M; Umesawa M; Waikar SS; Wen CP; Wetzels JFM; Woodward M; Grams ME; Kovesdy CP; Levey AS; Gansevoort RT; Appel LJ; Greene T; Chen TK; Chalmers J; Arima H; Perkovic V; Levin A; Djurdjev O; Tang M; Nally J; Navaneethan SD; Schold JD; Weldegiorgis M; Herrington WG; Smith M; Hsu CY; Hwang SJ; Chang AR; Kirchner HL; Green JA; Ho K; Marks A; Prescott G; Clark LE; Fluck N; Shalev V; Chodick G; Blankestijn PJ; Van Zuilen A; Van den Brand JA; Sarnak MJ; Bottinger E; Nadkarni GN; Ellis SG; Nadukuru R; Metzger M; Flamant M; Houillier P; Haymann JP; Froissart M; Kenealy T; Elley RC; Collins JF; Drury PL; Cuddeback JK; Ciemins EL; Stempniewicz R; Nelson RG; Knowler WC; Bakker SJ; Major RW; Medcalf JF; Shepherd D; Barrett-Connor E; Bergstrom J; Ix JH; Molnar MZ; Sumida K; de Zeeuw D; Brenner B; Qureshi AR; Elinder CG; Runesson B; Evans M; Segelmark M; Stendahl M; Schön S; Naimark DM; Tangri N, 2019, 'Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies', The Lancet Diabetes and Endocrinology, vol. 7, pp. 115 - 127, http://dx.doi.org/10.1016/S2213-8587(18)30313-9
2019
McGuire DK; Alexander JH; Johansen OE; Perkovic V; Rosenstock J; Cooper ME; Wanner C; Kahn SE; Toto RD; Zinman B; Baanstra D; Pfarr E; Schnaidt S; Meinicke T; George JT; Von Eynatten M; Marx N, 2019, 'Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA', Circulation, vol. 139, pp. 351 - 361, http://dx.doi.org/10.1161/CIRCULATIONAHA.118.038352
2019
Thompson A; Carroll K; Inker LA; Floege J; Perkovic V; Boyer-Suavet S; Major RW; Schimpf JI; Barratt J; Cattran DC; Gillespie BS; Kausz A; Mercer AW; Reich HN; Rovin BH; West M; Nachman PH, 2019, 'Proteinuria reduction as a surrogate end point in trials of IgA nephropathy', Clinical Journal of the American Society of Nephrology, vol. 14, pp. 469 - 481, http://dx.doi.org/10.2215/CJN.08600718
2019
Bello AK; Levin A; Lunney M; Osman MA; Ye F; Ashuntantang GE; Bellorin-Font E; Benghanem Gharbi M; Davison SN; Ghnaimat M; Harden P; Htay H; Jha V; Kalantar-Zadeh K; Kerr PG; Klarenbach S; Kovesdy CP; Luyckx VA; Neuen BL; O'Donoghue D; Ossareh S; Perl J; Rashid HU; Rondeau E; See E; Saad S; Sola L; Tchokhonelidze I; Tesar V; Tungsanga K; Turan Kazancioglu R; Wang AYM; Wiebe N; Yang CW; Zemchenkov A; Zhao MH; Jager KJ; Caskey F; Perkovic V; Jindal KK; Okpechi IG; Tonelli M; Feehally J; Harris DC; Johnson DW, 2019, 'Status of care for end stage kidney disease in countries and regions worldwide: International cross sectional survey', The BMJ, vol. 367, http://dx.doi.org/10.1136/bmj.l5873
2019
Smyth B; Trongtrakul K; Haber A; Talbot B; Hawley C; Perkovic V; Woodward M; Jardine M, 2019, 'Inequities in the global representation of sites participating in large, multicentre dialysis trials: A systematic review', BMJ Global Health, vol. 4, http://dx.doi.org/10.1136/bmjgh-2019-001940
2019
Mahaffey KW; Jardine MJ; Bompoint S; Cannon CP; Neal B; Heerspink HJL; Charytan DM; Edwards R; Agarwal R; Bakris G; Bull S; Capuano G; De Zeeuw D; Greene T; Levin A; Pollock C; Sun T; Wheeler DC; Yavin Y; Zhang H; Zinman B; Rosenthal N; Brenner BM; Perkovic V, 2019, 'Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results from the Randomized CREDENCE Trial', Circulation, vol. 140, pp. 739 - 750, http://dx.doi.org/10.1161/CIRCULATIONAHA.119.042007
2019
Zhan Z; Smyth B; Toussaint ND; Gray NA; Zuo L; De Zoysa JR; Chan CT; Jin C; Scaria A; Hawley CM; Perkovic V; Jardine MJ; Zhang L, 2019, 'Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study', BMC Nephrology, vol. 20, http://dx.doi.org/10.1186/s12882-019-1438-3
2019
Cooper ME; Perkovic V; Groop PH; Hocher B; Hehnke U; Meinicke T; Koitka-Weber A; van der Walt S; von Eynatten M, 2019, 'Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin with renin-angiotensin system inhibitors in type 2 diabetic patients with albuminuria', Journal of hypertension, vol. 37, pp. 1294 - 1300, http://dx.doi.org/10.1097/HJH.0000000000002032
2019
Toyama T; Neuen BL; Jun M; Ohkuma T; Neal B; Jardine MJ; Heerspink HL; Wong MG; Ninomiya T; Wada T; Perkovic V, 2019, 'Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis', Diabetes, Obesity and Metabolism, vol. 21, pp. 1237 - 1250, http://dx.doi.org/10.1111/dom.13648
2019
Smyth B; van den Broek-Best O; Hong D; Howard K; Rogers K; Zuo L; Gray NA; de Zoysa JR; Chan CT; Lin H; Zhang L; Xu J; Cass A; Gallagher M; Perkovic V; Jardine M, 2019, 'Varying association of extended hours dialysis with quality of life', Clinical Journal of the American Society of Nephrology, vol. 14, pp. 1751 - 1762, http://dx.doi.org/10.2215/CJN.06800619
2019
Inker LA; Heerspink HJL; Tighiouart H; Levey AS; Coresh J; Gansevoort RT; Simon AL; Ying J; Beck GJ; Wanner C; Floege J; Li PKT; Perkovic V; Vonesh EF; Greene T, 2019, 'GFR slope as a surrogate end point for kidney disease progression in clinical trials: A meta-analysis of treatment effects of randomized controlled trials', Journal of the American Society of Nephrology, vol. 30, pp. 1735 - 1745, http://dx.doi.org/10.1681/ASN.2019010007
2019
Lioufas N; Toussaint ND; Pedagogos E; Elder G; Badve SV; Pascoe E; Valks A; Hawley C; Block GA; Boudville NC; Campbell K; Cameron JD; Chen SSM; Faull RJ; Holt SG; Hooi LS; Jackson D; Jardine MJ; Johnson DW; Kerr PG; Lau KK; Morrish A; Perkovic V; Polkinghorne KR; Pollock CA; Reidlinger D; Robison L; Smith ER; Walker RJ; Wang AYM, 2019, 'Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction on Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study', BMJ Open, vol. 9, pp. e024382, http://dx.doi.org/10.1136/bmjopen-2018-024382
2019
Garg AX; Chan MTV; Cuerden MS; Devereaux PJ; Abbasi SH; Hildebrand A; Lamontagne F; Lamy A; Noiseux N; Parikh CR; Perkovic V; Quantz M; Rochon A; Royse A; Sessler DI; Shah PJ; Sontrop JM; Tagarakis GI; Teoh KH; Vincent J; Walsh M; Yared JP; Yusuf S; Whitlock RP, 2019, 'Effect of methylprednisolone on acute kidney injury in patients undergoing cardiac surgery with a cardiopulmonary bypass pump: A randomized controlled trial', CMAJ, vol. 191, pp. E247 - E256, http://dx.doi.org/10.1503/cmaj.181644
2019
Inker LA; Grams ME; Levey AS; Coresh J; Cirillo M; Collins JF; Gansevoort RT; Gutierrez OM; Hamano T; Heine GH; Ishikawa S; Jee SH; Kronenberg F; Landray MJ; Miura K; Nadkarni GN; Peralta CA; Rothenbacher D; Schaeffner E; Sedaghat S; Shlipak MG; Zhang L; van Zuilen AD; Hallan SI; Kovesdy CP; Woodward M; Levin A; Astor B; Appel L; Greene T; Chen T; Chalmers J; Arima H; Perkovic V; Yatsuya H; Tamakoshi K; Li Y; Hirakawa Y; Matsushita K; Sang Y; Polkinghorne K; Chadban S; Atkins R; Djurdjev O; Liu L; Zhao M; Wang F; Wang J; Ebert N; Martus P; Tang M; Emrich I; Seiler S; Zawada A; Nally J; Navaneethan S; Schold J; Sarnak M; Katz R; Hiramoto J; Iso H; Yamagishi K; Umesawa M; Muraki I; Fukagawa M; Maruyama S; Hasegawa T; Fujii N; Wheeler D; Emberson J; Townend J; Brenner H; Schöttker B; Saum KU; Fox C; Hwang SJ; Köttgen A; Schneider MP; Eckardt KU; Green J; Kirchner HL; Chang AR; Ho K; Ito S; Miyazaki M; Nakayama M; Yamada G; Irie F; Sairenchi T; Yano Y; Kotani K; Nakamura T; Kimm H; Mok Y; Chodick G; Shalev V; Wetzels JFM; Blankestijn PJ; van den Brand J; Kollerits B, 2019, 'Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium', American Journal of Kidney Diseases, vol. 73, pp. 206 - 217, http://dx.doi.org/10.1053/j.ajkd.2018.08.013
2019
Verma S; Mazer CD; Perkovic V, 2019, 'Is it time to REWIND the cardiorenal clock in diabetes?', The Lancet, vol. 394, pp. 95 - 97, http://dx.doi.org/10.1016/S0140-6736(19)31267-X
2019
Atkins ER; Perkovic V, 2019, 'Blood pressure: At what level is treatment worthwhile?', Australian Prescriber, vol. 42, pp. 127 - 130, http://dx.doi.org/10.18773/austprescr.2019.038
2019
Figtree GA; Rådholm K; Barrett TD; Perkovic V; Mahaffey KW; De Zeeuw D; Fulcher G; Matthews DR; Shaw W; Neal B, 2019, 'Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus: Results From the CANVAS Program', Circulation, vol. 139, pp. 2591 - 2593, http://dx.doi.org/10.1161/CIRCULATIONAHA.119.040057
2019
Jun M; Jardine MJ; Perkovic V; Pilard Q; Billot L; Rodgers A; Rogers K; Gallagher M, 2019, 'Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study', PLoS ONE, vol. 14, pp. e0213192, http://dx.doi.org/10.1371/journal.pone.0213192
2019
Jardine MJ; Li N; Ninomiya T; Feng X; Zhang J; Shi J; Zhang Y; Zhang R; Zhang J; Hao J; Perkovic V; Heerspink HL; Wu Y; Yan LL; Neal B, 2019, 'Dietary Sodium Reduction Reduces Albuminuria: A Cluster Randomized Trial', Journal of Renal Nutrition, vol. 29, pp. 276 - 284, http://dx.doi.org/10.1053/j.jrn.2018.10.009
2019
Ohkuma T; Jun M; Rodgers A; Cooper ME; Glasziou P; Hamet P; Harrap S; Mancia G; Marre M; Neal B; Perkovic V; Poulter N; Williams B; Zoungas S; Chalmers J; Woodward M, 2019, 'Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus', Hypertension (Dallas, Tex. : 1979), vol. 73, pp. 84 - 91, http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.12060
2019
Gray NA; Zuo L; Hong D; Smyth B; Jun M; De Zoysa J; Vo K; Howard K; Wang J; Lu C; Liu Z; Cass A; Perkovic V; Jardine M, 2019, 'Quality of life in caregivers compared with dialysis recipients: The Co-ACTIVE sub-study of the ACTIVE dialysis trial', Nephrology, vol. 24, pp. 1056 - 1063, http://dx.doi.org/10.1111/nep.13530
2019
Rosenstock J; Perkovic V; Johansen OE; Cooper ME; Kahn SE; Marx N; Alexander JH; Pencina M; Toto RD; Wanner C; Zinman B; Woerle HJ; Baanstra D; Pfarr E; Schnaidt S; Meinicke T; George JT; Von Eynatten M; McGuire DK, 2019, 'Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults with Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial', JAMA - Journal of the American Medical Association, vol. 321, pp. 69 - 79, http://dx.doi.org/10.1001/jama.2018.18269
2019
Perkovic V; Jardine MJ; Neal B; Bompoint S; Heerspink HJL; Charytan DM; Edwards R; Agarwal R; Bakris G; Bull S; Cannon CP; Capuano G; Chu PL; De Zeeuw D; Greene T; Levin A; Pollock C; Wheeler DC; Yavin Y; Zhang H; Zinman B; Meininger G; Brenner BM; Mahaffey KW, 2019, 'Canagliflozin and renal outcomes in type 2 diabetes and nephropathy', New England Journal of Medicine, vol. 380, pp. 2295 - 2306, http://dx.doi.org/10.1056/NEJMoa1811744
2019
Li JW; Badve SV; Zhou Z; Rodgers A; Day R; Oh R; Lee M; Perkovic V; de Zeeuw D; Mahaffey KW; Fulcher G; Matthews DR; Neal B, 2019, 'The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program', The Lancet Rheumatology, vol. 1, pp. e220 - e228, http://dx.doi.org/10.1016/S2665-9913(19)30078-5
2019
Liao JL; van den Broek-Best O; Smyth B; Hong D; Vo K; Zuo L; Gray NA; Chan CT; de Zoysa J; Perkovic V; Jiang L; Jardine M, 2019, 'Effect of extended hours dialysis on sleep quality in a randomized trial', Nephrology, vol. 24, pp. 430 - 437, http://dx.doi.org/10.1111/nep.13236
2019
Rådholm K; Wu JH; Wong MG; Foote C; Fulcher G; Mahaffey KW; Perkovic V; Neal B, 2018, 'Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes – A systematic review', Diabetes Research and Clinical Practice, vol. 140, pp. 118 - 128, http://dx.doi.org/10.1016/j.diabres.2018.03.027
2018
Neuen BL; Perkovic V, 2018, 'Reducing cardiovascular risk in people with diabetes and kidney disease', The Medical journal of Australia, vol. 209, pp. 438 - 439, http://dx.doi.org/10.5694/mja18.00929
2018
Wong MG; Jardine M; Perkovic V, 2018, 'Glucose lowering and the kidney: are all drug classes equal?', The Lancet Diabetes and Endocrinology, vol. 6, pp. 835 - 837, http://dx.doi.org/10.1016/S2213-8587(18)30291-2
2018
Matthews DR; Perkovic V; Mahaffey KW, 2018, 'Letter by Matthews et al Regarding Article, "Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist"', Circulation, vol. 138, pp. 660 - 661, http://dx.doi.org/10.1161/CIRCULATIONAHA.118.035717
2018
Jardine MJ; Mahaffey KW; Neal B; Agarwal R; Bakris GL; Brenner BM; Bull S; Cannon CP; Charytan DM; De Zeeuw D; Edwards R; Greene T; Heerspink HJL; Levin A; Pollock C; Wheeler DC; Xie J; Zhang H; Zinman B; Desai M; Perkovic V, 2018, 'The canagliflozin and renal endpoints in diabetes with established nephropathy clinical evaluation (CREDENCE) study rationale, design, and baseline characteristics', American Journal of Nephrology, vol. 46, pp. 462 - 472, http://dx.doi.org/10.1159/000484633
2018
Perkovic V; de Zeeuw D; Mahaffey KW; Fulcher G; Erondu N; Shaw W; Barrett TD; Weidner-Wells M; Deng H; Matthews DR; Neal B, 2018, 'Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials', The Lancet Diabetes and Endocrinology, vol. 6, pp. 691 - 704, http://dx.doi.org/10.1016/S2213-8587(18)30141-4
2018
de Zeeuw D; Renfurm RW; Bakris G; Rossing P; Perkovic V; Hou FF; Nangaku M; Sharma K; Heerspink HJL; Garcia-Hernandez A; Larsson TE, 2018, 'Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial', The Lancet Diabetes and Endocrinology, vol. 6, pp. 925 - 933, http://dx.doi.org/10.1016/S2213-8587(18)30289-4
2018
Jun M; Ohkuma T; Zoungas S; Colagiuri S; Mancia G; Marre M; Matthews D; Poulter N; Williams B; Rodgers A; Perkovic V; Chalmers J; Woodward M, 2018, 'Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results from ADVANCE-ON', Diabetes Care, vol. 41, pp. 163 - 170, http://dx.doi.org/10.2337/dc17-1467
2018
Heerspink HJL; Perkovic V, 2018, 'Trial design innovations to accelerate therapeutic advances in chronic kidney disease: Moving from single trials to an ongoing platform', Clinical Journal of the American Society of Nephrology, vol. 13, pp. 946 - 948, http://dx.doi.org/10.2215/CJN.01290118
2018
Pecoits-Filho R; Perkovic V, 2018, 'Are SGLT2 inhibitors ready for prime time for CKD?', Clinical Journal of the American Society of Nephrology, vol. 13, pp. 318 - 320, http://dx.doi.org/10.2215/CJN.07680717
2018
Okpechi IG; Alrukhaimi M; Ashuntantang GE; Bellorin-Font E; Benghanem Gharbi M; Braam B; Feehally J; Harris DC; Jha V; Jindal K; Johnson DW; Kalantar-Zadeh K; Kazancioglu R; Levin A; Lunney M; Olanrewaju TO; Perkovic V; Perl J; Rashid HU; Rondeau E; Salako BL; Samimi A; Sola L; Tchokhonelidze I; Wiebe N; Yang CW; Ye F; Zemchenkov A; Zhao MH; Bello AK, 2018, 'Global capacity for clinical research in nephrology: a survey by the International Society of Nephrology', Kidney International Supplements, vol. 8, pp. 82 - 89, http://dx.doi.org/10.1016/j.kisu.2017.10.012
2018
Smyth B; Perkovic V, 2018, 'New hypoglycemic agents and the kidney: What do the major trials tell us? [version 1; referees: 2 approved]', F1000Research, vol. 7, http://dx.doi.org/10.12688/f1000research.16135.1
2018
Rosenstock J; Perkovic V; Alexander JH; Cooper ME; Marx N; Pencina MJ; Toto RD; Wanner C; Zinman B; Baanstra D; Pfarr E; Mattheus M; Broedl UC; Woerle HJ; George JT; von Eynatten M; McGuire DK, 2018, 'Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): A randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk', Cardiovascular Diabetology, vol. 17, http://dx.doi.org/10.1186/s12933-018-0682-3
2018
Mahaffey KW; Neal B; Perkovic V; De Zeeuw D; Fulcher G; Erondu N; Shaw W; Fabbrini E; Sun T; Li Q; Desai M; Matthews DR, 2018, 'Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results from the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)', Circulation, vol. 137, pp. 323 - 334, http://dx.doi.org/10.1161/CIRCULATIONAHA.117.032038
2018
Heerspink HJL; List J; Perkovic V, 2018, 'New clinical trial designs for establishing drug efficacy and safety in a precision medicine era', Diabetes, Obesity and Metabolism, vol. 20, pp. 14 - 18, http://dx.doi.org/10.1111/dom.13417
2018
Heerspink HJL; Andress DL; Bakris G; Brennan JJ; Correa-Rotter R; Dey J; Hou FF; Kitzman DW; Kohan D; Makino H; McMurray J; Perkovic V; Tobe S; Wigderson M; Parving HH; de Zeeuw D, 2018, 'Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy', Diabetes, Obesity and Metabolism, vol. 20, pp. 1369 - 1376, http://dx.doi.org/10.1111/dom.13245
2018
Mohammedi K; Chalmers J; Herrington W; Li Q; Mancia G; Marre M; Poulter N; Rodgers A; Williams B; Perkovic V; Coresh J; Woodward M, 2018, 'Associations between body mass index and the risk of renal events in patients with type 2 diabetes', Nutrition and Diabetes, vol. 8, http://dx.doi.org/10.1038/s41387-017-0012-y
2018
Lo C; Toyama T; Wang Y; Lin J; Hirakawa Y; Jun M; Cass A; Hawley CM; Pilmore H; Badve SV; Perkovic V; Zoungas S, 2018, 'Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease', Cochrane Database of Systematic Reviews, vol. 2018, http://dx.doi.org/10.1002/14651858.CD011798.pub2
2018
Wong MG; Heerspink HJL; Perkovic V, 2018, 'ACCORDION: Ensuring that we hear the music clearly', Clinical Journal of the American Society of Nephrology, vol. 13, pp. 1621 - 1623, http://dx.doi.org/10.2215/CJN.11370918
2018
Tong A; Manns B; Wang AYM; Hemmelgarn B; Wheeler DC; Gill J; Tugwell P; Pecoits-Filho R; Crowe S; Harris T; Van Biesen W; Winkelmayer WC; Levin A; Thompson A; Perkovic V; Ju A; Gutman T; Bernier-Jean A; Viecelli AK; O'Lone E; Shen J; Josephson MA; Cho Y; Johnson DW; Sautenet B; Tonelli M; Craig JC; Sinha A; Ong A; Denny A; Dart A; Eddy A; Kelly A; Davenport A; Narva A; Sharma A; Warrens A; Chapman A; Teixeira-Pinto A; Murphy B; Padilla B; Canaud B; Pullin B; Schiller B; Robinson B; Hanson C; Hawley C; Logeman C; Lok C; Wanner C; Herzog C; Rutherford C; Ahn C; Sumpton D; Rosenbloom D; Harris D; Baron D; White D; Gipson D; Fouque D; Eilers D; Bockenhauer D; O'Donoghue D; Chen D; Dunning D; Brown E; Bavlovlenkov E; Mannon E; Poggio E; Chemla E; Dobbels F; Zannad F; Caskey F; Tentori F; Hurst F; Schaefer F; Wong G; Brunier G; Strippoli G; Rangan G; Knoll G; Obrador G; Feldman H; Coolican H; Yap HK; Groothoff J; Sloand J; Tan J; Locke J; Perl J; Chapman J; Dong J; Malyszko J; Fox J; Dapueto J; Tze-Wah Kao J; Chow KM; Manera K; Azukaitis K; Polkinghorne K, 2018, 'Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop', Kidney International, vol. 94, pp. 1053 - 1068, http://dx.doi.org/10.1016/j.kint.2018.08.018
2018
de Zeeuw D; Heerspink HJL; Jardine M; Perkovic V, 2018, 'Renal trials in diabetes need a platform: time for a global approach?', The Lancet Diabetes and Endocrinology, vol. 6, pp. 356 - 358, http://dx.doi.org/10.1016/S2213-8587(17)30263-2
2018
Rådholm K; Figtree G; Perkovic V; Solomon SD; Mahaffey KW; De Zeeuw D; Fulcher G; Barrett TD; Shaw W; Desai M; Matthews DR; Neal B, 2018, 'Canagliflozin and heart failure in type 2 diabetes mellitus: Results from the CANVAS program', Circulation, vol. 138, pp. 458 - 468, http://dx.doi.org/10.1161/CIRCULATIONAHA.118.034222
2018
Heerspink HJL; Andress DL; Bakris G; Brennan JJ; Correa-Rotter R; Hou FF; Kitzman DW; Kohan D; Makino H; McMurray J; Perkovic V; Tobe S; Wigderson M; Yi T; Parving HH; de Zeeuw D, 2018, 'Baseline characteristics and enrichment results from the SONAR trial', Diabetes, Obesity and Metabolism, vol. 20, pp. 1829 - 1835, http://dx.doi.org/10.1111/dom.13315
2018
Neuen BL; Ohkuma T; Neal B; Matthews DR; De Zeeuw D; Mahaffey KW; Fulcher G; Desai M; Li Q; Deng H; Rosenthal N; Jardine MJ; Bakris G; Perkovic V, 2018, 'Cardiovascular and renal outcomes with canagliflozin according to baseline kidney function data from the CANVAS program', Circulation, vol. 138, pp. 1537 - 1550, http://dx.doi.org/10.1161/CIRCULATIONAHA.118.035901
2018
Neuen BL; Chadban SJ; Demaio AR; Johnson DW; Perkovic V, 2017, 'Chronic kidney disease and the global NCDs agenda', BMJ Global Health, vol. 2, http://dx.doi.org/10.1136/bmjgh-2017-000380
2017
Jardine MJ; Zuo L; Gray NA; De Zoysa JR; Chan CT; Gallagher MP; Monaghan H; Grieve SM; Puranik R; Lin H; Eris JM; Zhang L; Xu J; Howard K; Lo S; Cass A; Perkovic V, 2017, 'A trial of extending hemodialysis hours and quality of life', Journal of the American Society of Nephrology, vol. 28, pp. 1898 - 1911, http://dx.doi.org/10.1681/ASN.2015111225
2017
Jun M; James MT; Ma Z; Zhang J; Tonelli M; McAlister FA; Manns BJ; Ravani P; Quinn RR; Wiebe N; Perkovic V; Wilton SB; Winkelmayer WC; Hemmelgarn BR, 2017, 'Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation', American Journal of Kidney Diseases, vol. 69, pp. 734 - 743, http://dx.doi.org/10.1053/j.ajkd.2016.10.018
2017
Webb DJ; Coll B; Heerspink HJL; Andress D; Pritchett Y; Brennan JJ; Houser M; Correa-Rotter R; Kohan D; Makino H; Perkovic V; Remuzzi G; Tobe SW; Toto R; Busch R; Pergola P; Parving HH; de Zeeuw D, 2017, 'Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial', Drugs in R and D, vol. 17, pp. 441 - 448, http://dx.doi.org/10.1007/s40268-017-0201-0
2017
Liyanage T; Ninomiya T; Perkovic V; Woodward M; Stirnadel-Farrant H; Matsushita K; Iseki K; Seong HL; Monaghan H; Jha V, 2017, 'Chronic kidney disease in Asia: Protocol for a collaborative overview', Nephrology, vol. 22, pp. 456 - 462, http://dx.doi.org/10.1111/nep.12821
2017
Heerspink HJL; Desai M; Jardine M; Balis D; Meininger G; Perkovic V, 2017, 'Canagliflozin slows progression of renal function decline independently of glycemic effects', Journal of the American Society of Nephrology, vol. 28, pp. 368 - 375, http://dx.doi.org/10.1681/ASN.2016030278
2017
Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S, 2017, 'Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients', Cochrane Database of Systematic Reviews, vol. 2017, http://dx.doi.org/10.1002/14651858.CD009966.pub2
2017
Pena MJ; de Zeeuw D; Andress D; Brennan JJ; Correa-Rotter R; Coll B; Kohan DE; Makino H; Perkovic V; Remuzzi G; Tobe SW; Toto R; Parving HH; Sharma S; Corringham T; Sharma K; Heerspink HJL, 2017, 'The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy', Diabetes, Obesity and Metabolism, vol. 19, pp. 749 - 753, http://dx.doi.org/10.1111/dom.12864
2017
Neal B; Perkovic V; Mahaffey KW; Fulcher G; Erondu N; Desai M; Shaw W; Law G; Walton MK; Rosenthal N; de Zeeuw D; Matthews DR, 2017, 'Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials', Diabetes, Obesity and Metabolism, vol. 19, pp. 926 - 935, http://dx.doi.org/10.1111/dom.12924
2017
Jardine MJ; Kasiske B; Adu D; Alrukhaimi M; Ashuntantang GE; Basnet S; Chailimpamontree W; Craig JC; O'Donoghue DJ; Perkovic V; Powe NR; Roberts CJ; Suzuki Y; Tanaka T; Uhlig K, 2017, 'Closing the gap between evidence and practice in chronic kidney disease', Kidney International Supplements, vol. 7, pp. 114 - 121, http://dx.doi.org/10.1016/j.kisu.2017.07.006
2017
Yu J; Zhou Z; McEvoy RD; Anderson CS; Rodgers A; Perkovic V; Neal B, 2017, 'Association of positive airway pressure with cardiovascular events and death in adults with sleep apnea: A systematic review and meta-analysis', JAMA - Journal of the American Medical Association, vol. 318, pp. 156 - 166, http://dx.doi.org/10.1001/jama.2017.7967
2017
Neal B; Perkovic V; Matthews DR, 2017, 'The authors reply', New England Journal of Medicine, vol. 377, pp. 2099, http://dx.doi.org/10.1056/NEJMc1712572
2017
Levin A; Tonelli M; Bonventre J; Coresh J; Donner JA; Fogo AB; Fox CS; Gansevoort RT; Heerspink HJL; Jardine M; Kasiske B; Köttgen A; Kretzler M; Levey AS; Luyckx VA; Mehta R; Moe O; Obrador G; Pannu N; Parikh CR; Perkovic V; Pollock C; Stenvinkel P; Tuttle KR; Wheeler DC; Eckardt KU; Adu D; Agarwal SK; Alrukhaimi M; Anders HJ; Ashuntantang G; Basnet S; Bello AK; Chailimpamontree W; Correa-Rotter R; Craig J; Douthat WG; Feldman HI; Ganji MR; Garcia-Garcia G; Gharbi MB; Harris DC; Jha V; Johnson DW; Kazancioglu R; Langham R; Liu ZH; Massy ZA; Nangaku M; Nelson RG; O'Donoghue D; Okpechi I; Pecoits-Filho R; Powe NR; Remuzzi G; Roberts C; Rossert J; Sola L; Stengel B; M EKS; Suzuki Y; Tanaka T; Tatiyanupanwong S; Thomas B; Uhlig K; Walker R; White SL; Wiecek A; Yang CW, 2017, 'Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy', The Lancet, vol. 390, pp. 1888 - 1917, http://dx.doi.org/10.1016/S0140-6736(17)30788-2
2017
Perkovic V; Craig JC; Chailimpamontree W; Fox CS; Garcia-Garcia G; Benghanem Gharbi M; Jardine MJ; Okpechi IG; Pannu N; Stengel B; Tuttle KR; Uhlig K; Levey AS, 2017, 'Action plan for optimizing the design of clinical trials in chronic kidney disease', Kidney International Supplements, vol. 7, pp. 138 - 144, http://dx.doi.org/10.1016/j.kisu.2017.07.009
2017
Matsushita K; Ballew SH; Coresh J; Arima H; Ärnlöv J; Cirillo M; Ebert N; Hiramoto JS; Kimm H; Shlipak MG; Visseren FLJ; Gansevoort RT; Kovesdy CP; Shalev V; Woodward M; Kronenberg F; Chalmers J; Perkovic V; Grams ME; Sang Y; Schaeffner E; Martus P; Levin A; Djurdjev O; Tang M; Heine G; Seiler S; Zawada A; Emrich I; Sarnak M; Katz R; Brenner H; Schöttker B; Rothenbacher D; Saum KU; Köttgen A; Schneider M; Eckardt KU; Green J; Kirchner HL; Chang AR; Black C; Marks A; Prescott G; Clark L; Fluck N; Jee SH; Mok Y; Chodick G; Wetzels JFM; Blankestijn PJ; van Zuilen AD; Bots M; Peralta C; Hiromoto J; Bottinger E; Nadkarni GN; Ellis SB; Nadukuru R; Kenealy T; Elley CR; Collins JF; Drury PL; Bakker SJ; Heerspink HJL; Jassal SK; Bergstrom J; Ix JH; Barrett-Connor E; Kalantar-Zadeh K; Carrero JJ; Gasparini A; Qureshi AR; Barany P; Algra A; van der Graaf Y; Evans M; Segelmark M; Stendahl M; Schön S; Tangri N; Sud M; Naimark D; Lannfelt L; Larsson A; Hallan S; Levey AS; Chen J; Kwak L, 2017, 'Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data', The Lancet Diabetes and Endocrinology, vol. 5, pp. 718 - 728, http://dx.doi.org/10.1016/S2213-8587(17)30183-3
2017
Ren S; Wang Y; Xian L; Toyama T; Jardine M; Li G; Perkovic V; Hong D, 2017, 'Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis', PLoS ONE, vol. 12, http://dx.doi.org/10.1371/journal.pone.0184398
2017
Heerspink HJL; Makino H; Andress D; Brennan JJ; Correa-Rotter R; Coll B; Davis JW; Idler K; Kohan DE; Liu M; Perkovic V; Remuzzi G; Tobe SW; Toto R; Parving HH; de Zeeuw D, 2017, 'Comparison of exposure response relationship of atrasentan between North American and Asian populations', Diabetes, Obesity and Metabolism, vol. 19, pp. 545 - 552, http://dx.doi.org/10.1111/dom.12851
2017
Groop PH; Cooper ME; Perkovic V; Hocher B; Kanasaki K; Haneda M; Schernthaner G; Sharma K; Stanton RC; Toto R; Cescutti J; Gordat M; Meinicke T; Koitka-Weber A; Thiemann S; von Eynatten M, 2017, 'Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA-T2D trial', Diabetes, Obesity and Metabolism, vol. 19, pp. 1610 - 1619, http://dx.doi.org/10.1111/dom.13041
2017
Lv J; Zhang H; Wong MG; Jardine MJ; Hladunewich M; Jha V; Monaghan H; Zhao M; Barbour S; Reich H; Cattran D; Glassock R; Levin A; Wheeler D; Woodward M; Billot L; Chan TM; Liu ZH; Johnson DW; Cass A; Feehally J; Floege J; Remuzzi G; Wu Y; Agarwal R; Wang HY; Perkovic V, 2017, 'Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: The TESTING randomized clinical trial', JAMA - Journal of the American Medical Association, vol. 318, pp. 432 - 442, http://dx.doi.org/10.1001/jama.2017.9362
2017
Patel A; Pieper K; Myburgh JA; Perkovic V; Finfer S; Yang Q; Li Q; Billot L, 2017, 'Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST)', New England Journal of Medicine, vol. 377, pp. 298 - 300, http://dx.doi.org/10.1056/NEJMc1703337
2017
Neal B; Perkovic V; Mahaffey KW; De Zeeuw D; Fulcher G; Erondu N; Shaw W; Law G; Desai M; Matthews DR, 2017, 'Canagliflozin and cardiovascular and renal events in type 2 diabetes', New England Journal of Medicine, vol. 377, pp. 644 - 657, http://dx.doi.org/10.1056/NEJMoa1611925
2017
Neal B; Perkovic V; Matthews DR; Mahaffey KW; Fulcher G; Meininger G; Erondu N; Desai M; Shaw W; Vercruysse F; Yee J; Deng H; de Zeeuw D, 2017, 'Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal (CANVAS-R): A randomized, placebo-controlled trial', Diabetes, Obesity and Metabolism, vol. 19, pp. 387 - 393, http://dx.doi.org/10.1111/dom.12829
2017
Su X; Xie X; Liu L; Lv J; Song F; Perkovic V; Zhang H, 2017, 'Comparative Effectiveness of 12 Treatment Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-analysis', American Journal of Kidney Diseases, vol. 69, pp. 69 - 77, http://dx.doi.org/10.1053/j.ajkd.2016.07.033
2017
Marx N; McGuire DK; Perkovic V; Woerle HJ; Broedl UC; Von Eynatten M; George JT; Rosenstock J, 2017, 'Composite primary end points in cardiovascular outcomes trials involving type 2 diabetes patients: Should unstable angina be included in the primary end point?', Diabetes Care, vol. 40, pp. 1144 - 1151, http://dx.doi.org/10.2337/dc17-0068
2017
Atkins ER; Hirakawa Y; Salam A; Woodward M; Cooper M; Hamet P; Harrap S; Lees K; Liu L; Mancia G; Marre M; Perkovic V; Poulter N; Williams B; Chalmers J; Rodgers A, 2017, 'Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: An analysis of the PROGRESS and ADVANCEtrials', Journal of Hypertension, vol. 35, pp. 1318 - 1325, http://dx.doi.org/10.1097/HJH.0000000000001287
2017
Gummer J; Trengove R; Pascoe EM; Badve SV; Cass A; Clarke P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW; Olynyk JK; Ferrari P, 2017, 'Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial', Nephrology, vol. 22, pp. 548 - 554, http://dx.doi.org/10.1111/nep.12815
2017
Sukkar L; Hong D; Wong MG; Badve SV; Rogers K; Perkovic V; Walsh M; Yu X; Hillis GS; Gallagher M; Jardine M, 2016, 'Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: Systematic review and meta-analysis', BMJ (Online), vol. 355, http://dx.doi.org/10.1136/bmj.i5599
2016
Xie X; Atkins E; Lv J; Bennett A; Neal B; Ninomiya T; Woodward M; MacMahon S; Turnbull F; Hillis GS; Chalmers J; Mant J; Salam A; Rahimi K; Perkovic V; Rodgers A, 2016, 'Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: Updated systematic review and meta-analysis', The Lancet, vol. 387, pp. 435 - 443, http://dx.doi.org/10.1016/S0140-6736(15)00805-3
2016
Perkovic V; Agarwal R; Fioretto P; Hemmelgarn BR; Levin A; Thomas MC; Wanner C; Kasiske BL; Wheeler DC; Groop PH; Bakris GL; Cooper ME; Chae DW; Davidson MH; de Boer IH; de Zeeuw D; Fornoni A; Gnudi L; Herzog CA; Hung AM; Jafar TH; Jardine M; Jha V; Ji L; Kahn SE; Langham RG; Lerma EV; Ma RCW; Makino H; Marre M; Mauer M; Metsärinne K; Nelson RG; Pecoits-Filho R; Pollock CA; Rajapurkar M; Rossing P; Rychlík I; Sharma K; Stanton RC; Tesař V; Tikkanen I; Tomson CRV; Toto RD; Tsukamoto Y; Tuttle KR; Wada T; Williams WW; Zhang H; Zoungas S, 2016, 'Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference', Kidney International, vol. 90, pp. 1175 - 1183, http://dx.doi.org/10.1016/j.kint.2016.09.010
2016
Wong MG; Perkovic V; Chalmers J; Woodward M; Li Q; Cooper ME; Hamet P; Harrap S; Heller S; Macmahon S; Mancia G; Marre M; Matthews D; Neal B; Poulter N; Rodgers A; Williams B; Zoungas S, 2016, 'Long-term benefits of intensive glucose Control for preventing end-stage kidney disease: ADVANCE-ON', Diabetes Care, vol. 39, pp. 694 - 700, http://dx.doi.org/10.2337/dc15-2322
2016
Dal-Ré R; Jha V; Lv J; Chaudhury RR; Wang Y; Perkovic V, 2016, 'International trials in middle-income countries: different local scenarios require different ethical approaches', Journal of the Royal Society of Medicine, vol. 109, pp. 47 - 51, http://dx.doi.org/10.1177/0141076815608854
2016
Fulcher G; Matthews DR; Perkovic V; de Zeeuw D; Mahaffey KW; Mathieu C; Woo V; Wysham C; Capuano G; Desai M; Shaw W; Vercruysse F; Meininger G; Neal B; Home P; Anderson J; Campbell I; Lachin J; Scharfstein D; Solomon S; Uzzo R; Amerena J; Chow C; Figtree G; French G; Hillis J; Jenkins B; Lindley R; McGrath B; Street A; Watson J, 2016, 'Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes', Diabetes, Obesity and Metabolism, vol. 18, pp. 82 - 91, http://dx.doi.org/10.1111/dom.12589
2016
Rodgers A; Perkovic V, 2016, 'A randomized trial of intensive versus standard blood-pressure control [10]', New England Journal of Medicine, vol. 374, pp. 2295, http://dx.doi.org/10.1056/NEJMc1602668
2016
Patel MR; Armstrong PW; Bhatt DL; Braunwald E; Camm AJ; Fox KAA; Harrington RA; Hiatt WR; James SK; Kirtane AJ; Leon MB; Lincoff AM; Mahaffey KW; Mauri L; Mehran R; Mehta SR; Montalescot G; Nicholls SJ; Perkovic V; Peterson ED; Pocock SJ; Roe MT; Sabatine MS; Sekeres M; Solomon SD; Steg G; Stone GW; Van De Werf F; Wallentin L; White HD; Gibson CM, 2016, 'Sharing data from cardiovascular clinical trials \- a proposal', New England Journal of Medicine, vol. 375, pp. 407 - 409, http://dx.doi.org/10.1056/NEJMp1605260
2016
Wong MG; Perkovic V, 2016, 'Knowing what we do not know: statin therapy in advanced chronic kidney disease', The Lancet Diabetes and Endocrinology, vol. 4, pp. 801 - 803, http://dx.doi.org/10.1016/S2213-8587(16)30192-9
2016
Gabb GM; Mangoni A; Anderson CS; Cowley D; Dowden JS; Golledge J; Hankey GJ; Howes FS; Leckie L; Perkovic V; Schlaich M; Zwar NA; Medley TL; Arnolda L, 2016, 'Guideline for the diagnosis and management of hypertension in adults — 2016', Medical Journal of Australia, vol. 205, pp. 85 - 89, http://dx.doi.org/10.5694/mja16.00526
2016
Xie X; Liu Y; Perkovic V; Li X; Ninomiya T; Hou W; Zhao N; Liu L; Lv J; Zhang H; Wang H, 2016, 'Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients with CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials', American Journal of Kidney Diseases, vol. 67, pp. 728 - 741, http://dx.doi.org/10.1053/j.ajkd.2015.10.011
2016
Quach K; Lvtvyn L; Baigent C; Bueti J; Garg AX; Hawley C; Haynes R; Manns B; Perkovic V; Rabbat CG; Wald R; Walsh M, 2016, 'The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysis', American Journal of Kidney Diseases, vol. 68, pp. 591 - 598, http://dx.doi.org/10.1053/j.ajkd.2016.04.011
2016
Olsen MH; Angell SY; Asma S; Boutouyrie P; Burger D; Chirinos JA; Damasceno A; Delles C; Gimenez-Roqueplo AP; Hering D; López-Jaramillo P; Martinez F; Perkovic V; Rietzschel ER; Schillaci G; Schutte AE; Scuteri A; Sharman JE; Wachtell K; Wang JG, 2016, 'A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension', The Lancet, vol. 388, pp. 2665 - 2712, http://dx.doi.org/10.1016/S0140-6736(16)31134-5
2016
Gallagher M; Wong MG; Perkovic V, 2016, 'ALTITUDE: Defining a ceiling for blockade of the renin-angiotensin system?', The Lancet Diabetes and Endocrinology, vol. 4, pp. 289 - 290, http://dx.doi.org/10.1016/S2213-8587(15)00518-5
2016
Badve SV; Palmer SC; Strippoli GFM; Roberts MA; Teixeira-Pinto A; Boudville N; Cass A; Hawley CM; Hiremath SS; Pascoe EM; Perkovic V; Whalley GA; Craig JC; Johnson DW, 2016, 'The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis', American Journal of Kidney Diseases, vol. 68, pp. 554 - 563, http://dx.doi.org/10.1053/j.ajkd.2016.03.418
2016
Knight J; Perkovic V, 2016, 'The Affordable Dialysis Prize steams ahead', The Lancet, vol. 387, pp. 1040, http://dx.doi.org/10.1016/S0140-6736(16)00657-7
2016
Zhang L; Coombes J; Pascoe EM; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW, 2016, 'The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial', Redox Report, vol. 21, pp. 14 - 23, http://dx.doi.org/10.1179/1351000215Y.0000000022
2016
Nigwekar SU; Kang A; Zoungas S; Cass A; Gallagher MP; Kulshrestha S; Navaneethan SD; Perkovic V; Strippoli GFM; Jardine MJ, 2016, 'Interventions for lowering plasma homocysteine levels in dialysis patients', Cochrane Database of Systematic Reviews, vol. 2016, http://dx.doi.org/10.1002/14651858.CD004683.pub4
2016
Perkovic V, 2016, 'Commentary', Annals of Internal Medicine, vol. 165, pp. JC71, http://dx.doi.org/10.7326/ACPJC-2016-165-12-071
2016
Liyanage T; Ninomiya T; Wang A; Neal B; Jun M; Wong MG; Jardine M; Hillis GS; Perkovic V, 2016, 'Effects of the mediterranean diet on cardiovascular outcomes-a systematic review and meta-analysis', PLoS ONE, vol. 11, http://dx.doi.org/10.1371/journal.pone.0159252
2016
Roberts MA; Pilmore HL; Ierino FL; Badve SV; Cass A; Garg AX; Isbel NM; Krum H; Pascoe EM; Perkovic V; Scaria A; Tonkin AM; Vergara LA; Hawley CM; Levin A; Hare D; Martin A; Wheeler DC; Fulcher G; Brown H; Colquhoun D; Korczyk D; Mather A; Wong A; Bisscheroux P; Gillies A; Garvey L; Tan KS; Lennan E; Pitkin M; Ahearn K; Carroll RP; Scott E; Cooper B; Pearse J; Snelling P; Burman J; Hand S; Pedagogos E; Karschimkus C; Pilmore A; Walker R; Ellis G; Marshall MR; Paul C; Johnson D; Helyar J; Morrish A; Paul-Brent PA; Reidlinger D; Zhang L, 2016, 'The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) feasibility study: A randomized controlled trial', American Journal of Kidney Diseases, vol. 67, pp. 902 - 911, http://dx.doi.org/10.1053/j.ajkd.2015.10.029
2016
Wang Y; Ivany JN; Perkovic V; Gallagher MP; Woodward M; Jardine MJ, 2016, 'Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease', Cochrane Database of Systematic Reviews, vol. 2016, http://dx.doi.org/10.1002/14651858.CD009631.pub2
2016
Chan KE; Giugliano RP; Patel MR; Abramson S; Jardine M; Zhao S; Perkovic V; Maddux FW; Piccini JP, 2016, 'Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF', Journal of the American College of Cardiology, vol. 67, pp. 2888 - 2899, http://dx.doi.org/10.1016/j.jacc.2016.02.082
2016
Wu JHY; Foote C; Blomster J; Toyama T; Perkovic V; Sundström J; Neal B, 2016, 'Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: A systematic review and meta-analysis', The Lancet Diabetes and Endocrinology, vol. 4, pp. 411 - 419, http://dx.doi.org/10.1016/S2213-8587(16)00052-8
2016
Groop PH; Cooper ME; Perkovic V; Sharma K; Schernthaner G; Haneda M; Hocher B; Gordat M; Cescutti J; Woerle HJ; Von Eynatten M, 2015, 'Dipeptidyl peptidase-4 inhibition with linagliptin and effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: Rationale and design of the MARLINA-T2D trial', Diabetes and Vascular Disease Research, vol. 12, pp. 455 - 462, http://dx.doi.org/10.1177/1479164115579002
2015
Fulcher G; Matthews DR; Perkovic V; de Zeeuw D; Mahaffey KW; Weiss R; Rosenstock J; Capuano G; Desai M; Shaw W; Vercruysse F; Meininger G; Neal B, 2015, 'Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled Trial', Diabetes Therapy, vol. 6, pp. 289 - 302, http://dx.doi.org/10.1007/s13300-015-0117-z
2015
Emdin CA; Rahimi K; Neal B; Callender T; Perkovic V; Patel A, 2015, 'Blood pressure lowering in type 2 diabetes : A systematic review and meta-analysis', JAMA - Journal of the American Medical Association, vol. 313, pp. 603 - 615, http://dx.doi.org/10.1001/jama.2014.18574
2015
Badve SV; Zhang L; Coombes JS; Pascoe EM; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW; D'Almeida E; Fassett R; Kirkpatrick C; Phoon R, 2015, 'Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: A secondary analysis of the HERO trial', Canadian Journal of Kidney Health and Disease, vol. 2, http://dx.doi.org/10.1186/s40697-015-0066-5
2015
Perkovic V; Jardine M; Vijapurkar U; Meininger G, 2015, 'Renal effects of canagliflozin in type 2 diabetes mellitus', Current Medical Research and Opinion, vol. 31, pp. 2219 - 2231, http://dx.doi.org/10.1185/03007995.2015.1092128
2015
Tong A; Crowe S; Chando S; Cass A; Chadban SJ; Chapman JR; Gallagher M; Hawley CM; Hill S; Howard K; Johnson DW; Kerr PG; McKenzie A; Parker D; Perkovic V; Polkinghorne KR; Pollock C; Strippoli GFM; Tugwell P; Walker RG; Webster AC; Wong G; Craig JC, 2015, 'Research Priorities in CKD: Report of a National Workshop Conducted in Australia', American Journal of Kidney Diseases, vol. 66, pp. 212 - 222, http://dx.doi.org/10.1053/j.ajkd.2015.02.341
2015
Kang A; Nigwekar SU; Perkovic V; Kulshrestha S; Zoungas S; Navaneethan SD; Cass A; Gallagher MP; Ninomiya T; Strippoli GFM; Jardine MJ, 2015, 'Interventions for lowering plasma homocysteine levels in kidney transplant recipients', Cochrane Database of Systematic Reviews, vol. 2015, http://dx.doi.org/10.1002/14651858.CD007910.pub2
2015
Liyanage T; Ninomiya T; Jha V; Neal B; Patrice HM; Okpechi I; Zhao MH; Lv J; Garg AX; Knight J; Rodgers A; Gallagher M; Kotwal S; Cass A; Perkovic V, 2015, 'Worldwide access to treatment for end-stage kidney disease: A systematic review', The Lancet, vol. 385, pp. 1975 - 1982, http://dx.doi.org/10.1016/S0140-6736(14)61601-9
2015
Hillis GS; Welsh P; Chalmers J; Perkovic V; Chow CK; Li Q; Jun M; Neal B; Zoungas S; Poulter N; Mancia G; Williams B; Sattar N; Woodward M, 2015, 'Erratum. The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients With type 2 diabetes. Diabetes Care 2014;37:295-303', Diabetes Care, vol. 38, pp. 1393, http://dx.doi.org/10.2337/dc15-er07
2015
Jardine MJ; Zuo L; Gray NA; De Zoysa J; Chan CT; Gallagher MP; Howard K; Hertier S; Cass A; Perkovic V, 2015, 'Design and participant baseline characteristics of 'A Clinical Trial of IntensiVE Dialysis': The ACTIVE Dialysis Study', Nephrology, vol. 20, pp. 257 - 265, http://dx.doi.org/10.1111/nep.12385
2015
Jardine M; Perkovic V, 2015, 'First Light after the Long Night: A Follow-up Report of the Randomized FHN Nocturnal Trial', American Journal of Kidney Diseases, vol. 66, pp. 379 - 382, http://dx.doi.org/10.1053/j.ajkd.2015.06.007
2015
Schievink B; De Zeeuw D; Smink PA; Andress D; Brennan JJ; Coll B; Correa-Rotter R; Hou FF; Kohan D; Kitzman DW; Makino H; Parving HH; Perkovic V; Remuzzi G; Tobe S; Toto R; Hoekman J; Lambers Heerspink HJ, 2015, 'Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers', European Journal of Preventive Cardiology, vol. 23, pp. 758 - 768, http://dx.doi.org/10.1177/2047487315598709
2015
Perkovic V; Rodgers A, 2015, 'Redefining blood-pressure targets - SPRINT starts the marathon', New England Journal of Medicine, vol. 373, pp. 2175 - 2178, http://dx.doi.org/10.1056/NEJMe1513301
2015
Thomas MC; Woodward M; Neal B; Li Q; Pickering R; Marre M; Williams B; Perkovic V; Cooper ME; Zoungas S; Chalmers J; Hillis GS, 2015, 'Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes', Diabetes Care, vol. 38, pp. 1891 - 1897, http://dx.doi.org/10.2337/dc15-0925
2015
Cooper ME; Perkovic V; McGill JB; Groop PH; Wanner C; Rosenstock J; Hehnke U; Woerle HJ; Von Eynatten M, 2015, 'Kidney Disease End Points in a Pooled Analysis of Individual Patient-Level Data from a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes', American Journal of Kidney Diseases, vol. 66, pp. 441 - 449, http://dx.doi.org/10.1053/j.ajkd.2015.03.024
2015
Lo C; Toyama T; Hirakawa Y; Jun M; Cass A; Hawley C; Pilmore H; Badve S; Perkovic V; Zoungas S, 2015, 'Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease', Cochrane Database of Systematic Reviews, vol. 2015, http://dx.doi.org/10.1002/14651858.CD011798
2015
Toyama T; Furuichi K; Shimizu M; Hara A; Iwata Y; Sakai N; Perkovic V; Kobayashi M; Mano T; Kaneko S; Wada T, 2015, 'Relationship between serum uric acid levels and chronic kidney disease in a Japanese cohort with normal or mildly reduced kidney function', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0137449
2015
Jun M; Turin TC; Woodward M; Perkovic V; Lambers Heerspink HJ; Manns BJ; Tonelli M; Hemmelgarn BR, 2015, 'Assessing the validity of surrogate outcomes for ESRD: A meta-analysis', Journal of the American Society of Nephrology, vol. 26, pp. 2289 - 2302, http://dx.doi.org/10.1681/ASN.2014040396
2015
Roberts MA; Pilmore HL; Ierino FL; Badve SV; Cass A; Garg AX; Hawley CM; Isbel NM; Krum H; Pascoe EM; Tonkin AM; Vergara LA; Perkovic V, 2015, 'The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study', Nephrology, vol. 20, pp. 140 - 147, http://dx.doi.org/10.1111/nep.12362
2015
Kohan DE; Heerspink HJL; Coll B; Andress D; Brennan JJ; Kitzman DW; Correa-Rotter R; Makino H; Perkovic V; Hou FF; Remuzzi G; Tobe SW; Toto R; Parving HH; De Zeeuw D, 2015, 'Predictors of atrasentan-associated fluid retention and change in albuminuria in patients with diabetic nephropathy', Clinical Journal of the American Society of Nephrology, vol. 10, pp. 1568 - 1574, http://dx.doi.org/10.2215/CJN.00570115
2015
Johnson DW; Pascoe EM; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; D'Almeida E; Fassett R; Kirkpatrick C; Phoon R; Tonkin A; Forbes A; Levin A; Wheeler DC; Jardine M; Burman J; Hand S; Garvey L; Suranyi M; Gilbert M; Endre Z; McNamara K; Snelling P; Mahadevan K; Pollock A; Leary D; Ratanjee S; Kirby J; Juneja R; Hill K; Cook N; Bisscheroux P; McMahon L; Kent A; Raspudic M; Steinwandel U; Dogra S; Pellicano S; Paul-Brent PA, 2015, 'A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: The handling erythropoietin resistance with oxpentifylline (HERO) trial', American Journal of Kidney Diseases, vol. 65, pp. 49 - 57, http://dx.doi.org/10.1053/j.ajkd.2014.06.020
2015
Zhu B; Zhu CF; Lin Y; Perkovic V; Li XF; Yang R; Tang XL; Zhu XL; Cheng XX; Li Q; Chen HY; Sun Y; Chen QW; Wang YJ, 2015, 'Clinical characteristics of IgA nephropathy associated with low complement 4 levels', Renal Failure, vol. 37, pp. 424 - 432, http://dx.doi.org/10.3109/0886022X.2014.994408
2015
Laba TL; Usherwood T; Leeder S; Yusuf F; Gillespie J; Perkovic V; Wilson A; Jan S; Essue B, 2015, 'Co-payments for health care: What is their real cost?', Australian Health Review, vol. 39, pp. 33 - 36, http://dx.doi.org/10.1071/AH14087
2015
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GFM, 2015, 'HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis', Sao Paulo Medical Journal, vol. 133, pp. 541, http://dx.doi.org/10.1590/1516-3180.20151336T2
2015
Jun M; James MT; Manns BJ; Quinn RR; Ravani P; Tonelli M; Perkovic V; Winkelmayer WC; Ma Z; Hemmelgarn BR, 2015, 'The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: Population based observational study', The BMJ, vol. 350, http://dx.doi.org/10.1136/bmj.h246
2015
Agodoa L; Estacio R; Schrier R; Lubsen J; Chalmers J; Cutler J; Davis B; Wing L; Poulter NR; Sever P; Remuzzi G; Ruggenenti P; Nissen S; Lindholm LH; Fukui T; Ogihara T; Saruta T; Black H; Sleight P; Lievre M; Suzuki H; Fox K; Lisheng L; Ohkubo T; Imai Y; Yusuf S; Bulpitt CJ; Lewis E; Brown M; Palmer C; Wang J; Pepine C; Ishii M; Yui Y; Kuramoto K; Pfeff Er M; Asselbergs FW; Van Gilst WH; Byington B; Pitt B; Brenner B; Remme WJ; De Zeeuw D; Rahman M; Viberti G; Teo K; Zanchetti A; Malacco E; Mancia G; Staessen J; Fagard R; Holman R; Hansson L; Kostis J; Kanno Y; Lueders S; Matsuzaki M; Poole-Wilson P; Schrader J; Rahimi K; Anderson C; Chapman N; Collins R; MacMahon S; Neal B; Rodgers A; Whelton P; Woodward M, 2015, 'Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: A meta-analysis of randomised trials', The Lancet, vol. 385, pp. 867 - 874, http://dx.doi.org/10.1016/S0140-6736(14)61171-5
2015
Wong MG; Wanner C; Knight J; Perkovic V, 2015, 'Lowering cholesterol in chronic kidney disease: Is it safe and effective?', European Heart Journal, vol. 36, pp. 2988 - 2995, http://dx.doi.org/10.1093/eurheartj/ehv393
2015
Neal B; Perkovic V; De Zeeuw D; Mahaffey KW; Fulcher G; Ways K; Desai M; Shaw W; Capuano G; Alba M; Jiang J; Vercruysse F; Meininger G; Matthews D, 2015, 'Efficacy and safety of canaglif lozin, an inhibitor of sodium-glucose cotransporter 2, when used in conjunction with insulin therapy in patients with type 2 diabetes', Diabetes Care, vol. 38, pp. 403 - 411, http://dx.doi.org/10.2337/dc14-1237
2015
De Zeeuw D; Coll B; Andress D; Brennan JJ; Tang H; Houser M; Correa-Rotter R; Kohan D; Heerspink HJL; Makino H; Perkovic V; Pritchett Y; Remuzzi G; Tobe SW; Toto R; Viberti G; Parving HH, 2014, 'The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy', Journal of the American Society of Nephrology, vol. 25, pp. 1083 - 1093, http://dx.doi.org/10.1681/ASN.2013080830
2014
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GFM, 2014, 'HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis', Cochrane Database of Systematic Reviews, vol. 2014, http://dx.doi.org/10.1002/14651858.CD007784.pub2
2014
Perkovic V; Turnbull F; Wilson A, 2014, 'Is it time for medi-change?', Medical Journal of Australia, vol. 200, pp. 566 - 567, http://dx.doi.org/10.5694/mja14.00427
2014
Bose B; Badve SV; Hiremath SS; Boudville N; Brown FG; Cass A; De Zoysa JR; Fassett RG; Faull R; Harris DC; Hawley CM; Kanellis J; Palmer SC; Perkovic V; Pascoe EM; Rangan GK; Walker RJ; Walters G; Johnson DW, 2014, 'Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis', Nephrology Dialysis Transplantation, vol. 29, pp. 406 - 413, http://dx.doi.org/10.1093/ndt/gft378
2014
Sundström J; Arima H; Woodward M; Jackson R; Karmali K; Lloyd-Jones D; Baigent C; Emberson J; Rahimi K; Macmahon S; Patel A; Perkovic V; Turnbull F; Neal B; Agodoa L; Estacio R; Schrier R; Lubsen J; Chalmers J; Cutler J; Davis B; Wing L; Poulter NR; Sever P; Remuzzi G; Ruggenenti P; Nissen S; Lindholm LH; Fukui T; Ogihara T; Saruta T; Black H; Sleight P; Lievre M; Suzuki H; Fox K; Lisheng L; Ohkubo T; Imai Y; Yusuf S; Bulpitt CJ; Lewis E; Brown M; Palmer C; Wang J; Pepine C; Ishii M; Yui Y; Kuramoto K; Pfeffer M; Asselbergs FW; van Gilst WH; Byington B; Pitt B; Brenner B; Remme WJ; de Zeeuw D; Rahman M; Viberti G; Teo K; Zanchetti A; Malacco E; Mancia G; Staessen J; Fagard R; Holman R; Hansson L; Kostis J; Kanno Y; Lueders S; Matsuzaki M; Poole-Wilson P; Schrader J; Rahimi K; Anderson C; Chalmers J; Chapman N; Collins R; Neal B; Rodgers A; Whelton P; Woodward M; Yusuf S, 2014, 'Blood pressure-lowering treatment based on cardiovascular risk: A meta-analysis of individual patient data', The Lancet, vol. 384, pp. 591 - 598, http://dx.doi.org/10.1016/S0140-6736(14)61212-5
2014
Ninomiya T; Perkovic V, 2014, 'Authors' reply to Ladapo and Ogedegbe', BMJ (Online), vol. 348, http://dx.doi.org/10.1136/bmj.g148
2014
Zoungas S; Chalmers J; Neal B; Billot L; Li Q; Biostat M; Hirakawa Y; Arima H; Monaghan H; Joshi R; Colagiuri S; Cooper ME; Glasziou P; Grobbee D; Hamet P; Harrap S; Heller S; Lisheng L; Mancia G; Marre M; Matthews DR; Mogensen CE; Perkovic V; Poulter N; Rodgers A; Williams B; MacMahon S; Patel A; Woodward M, 2014, 'Follow-up of blood-pressure lowering and glucose control in type 2 diabetes', New England Journal of Medicine, vol. 371, pp. 1392 - 1406, http://dx.doi.org/10.1056/NEJMoa1407963
2014
Palmer SC; Navaneethan SD; Craig JC; Johnson DD; Perkovic V; Hegbrant J; Strippoli GFM, 2014, 'HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis', Sao Paulo Medical Journal, vol. 132, pp. 314, http://dx.doi.org/10.1590/1516-3180.20141325T1
2014
Huxley RR; Perkovic V, 2014, 'The modifiable burden of worldwide mortality from cardiovascular diseases', The Lancet Diabetes and Endocrinology, vol. 2, pp. 604 - 606, http://dx.doi.org/10.1016/S2213-8587(14)70040-3
2014
Morrish AT; Hawley CM; Johnson DW; Badve SV; Perkovic V; Reidlinger DM; Cass A, 2014, 'Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network', Kidney International, vol. 85, pp. 23 - 30, http://dx.doi.org/10.1038/ki.2013.391
2014
Wang AY; Ninomiya T; Al-Kahwa A; Perkovic V; Gallagher MP; Hawley C; Jardine MJ, 2014, 'Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: A systematic review and meta-analysis of randomized trials', American Journal of Kidney Diseases, vol. 63, pp. 968 - 978, http://dx.doi.org/10.1053/j.ajkd.2014.01.435
2014
Knight J; Wong MG; Perkovic V, 2014, 'Optimal targets for blood pressure control in chronic kidney disease: The debate continues', Current Opinion in Nephrology and Hypertension, vol. 23, pp. 541 - 546, http://dx.doi.org/10.1097/MNH.0000000000000060
2014
Huxley RR; Perkovic V, 2014, 'The modifiable burden of worldwide mortality from cardiovascular diseases', LANCET DIABETES & ENDOCRINOLOGY, vol. 2, pp. 604 - 606, http://dx.doi.org/10.1016/S2213-8587(14)70040-3
2014
Yamout H; Perkovic V; Davies M; Woo V; De Zeeuw D; Mayer C; Vijapurkar U; Kline I; Usiskin K; Meininger G; Bakris G, 2014, 'Efficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathy', American Journal of Nephrology, vol. 40, pp. 64 - 74, http://dx.doi.org/10.1159/000364909
2014
Hillis GS; Welsh P; Chalmers J; Perkovic V; Chow CK; Li Q; Jun M; Neal B; Zoungas S; Poulter N; Mancia G; Williams B; Sattar N; Woodward M, 2014, 'The relative and combined ability of high-sensitivity cardiac troponin t and n-terminal pro-b-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetes', Diabetes Care, vol. 37, pp. 295 - 303, http://dx.doi.org/10.2337/dc13-1165
2014
Palmer SC; Navaneethan SD; Craig JC; Perkovic V; Johnson DW; Nigwekar SU; Hegbrant J; Strippoli GFM, 2014, 'HMG CoA reductase inhibitors (statins) for kidney transplant recipients', Cochrane Database of Systematic Reviews, vol. 2014, http://dx.doi.org/10.1002/14651858.CD005019.pub4
2014
Pilmore H; Dogra G; Roberts M; Lambers Heerspink HJ; Ninomiya T; Huxley R; Perkovic V, 2014, 'Cardiovascular disease in patients with chronic kidney disease', Nephrology, vol. 19, pp. 3 - 10, http://dx.doi.org/10.1111/nep.12148
2014
Jardine MJ; Liyanage T; Buxton E; Perkovic V, 2013, 'MTOR inhibition in autosomal-dominant polycystic kidney disease (ADPKD): The question remains open', Nephrology Dialysis Transplantation, vol. 28, pp. 242 - 244, http://dx.doi.org/10.1093/ndt/gfs519
2013
Hou W; Lv JA; Perkovic V; Yang L; Zhao N; Jardine MJ; Cass A; Zhang H; Wang H, 2013, 'Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: A systematic review and meta-analysis', European Heart Journal, vol. 34, http://dx.doi.org/10.1093/eurheartj/eht065
2013
Groop PH; Cooper ME; Perkovic V; Emser A; Woerle HJ; Von Eynatten M, 2013, 'Linagliptin lowers albuminuria on top of recommended standard treatment in patients with type 2 diabetes and renal dysfunction', Diabetes Care, vol. 36, pp. 3460 - 3468, http://dx.doi.org/10.2337/dc13-0323
2013
Palmer SC; Di Micco L; Razavian M; Craig JC; Perkovic V; Pellegrini F; Jardine MJ; Webster AC; Zoungas S; Strippoli GFM, 2013, 'Antiplatelet agents for chronic kidney disease', Cochrane Database of Systematic Reviews, vol. 2013, http://dx.doi.org/10.1002/14651858.CD008834.pub3
2013
MacMahon S; Perkovic V; Patel A, 2013, 'Industry-sponsored clinical trials in emerging markets: Time to review the terms of engagement', JAMA - Journal of the American Medical Association, vol. 310, pp. 907 - 908, http://dx.doi.org/10.1001/jama.2013.276913
2013
Perkovic V; Woodward M; Zoungas S; Chalmers J, 2013, 'The authors reply', Kidney International, vol. 84, pp. 622, http://dx.doi.org/10.1038/ki.2013.241
2013
Wong MG; Perkovic V; Woodward M; Chalmers J; Li Q; Hillis GS; Yaghobian Azari D; Jun M; Poulter N; Hamet P; Williams B; Neal B; Mancia G; Cooper M; Pollock CA, 2013, 'Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus', Kidney International, vol. 83, pp. 278 - 284, http://dx.doi.org/10.1038/ki.2012.383
2013
Neal B; Perkovic V; De Zeeuw D; Mahaffey KW; Fulcher G; Stein P; Desai M; Shaw W; Jiang J; Vercruysse F; Meininger G; Matthews D, 2013, 'Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS) - A randomized placebo-controlled trial', American Heart Journal, vol. 166, http://dx.doi.org/10.1016/j.ahj.2013.05.007
2013
Perkovic V, 2013, 'Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: Meta-analysis of randomised controlled trials', BMJ (Online), vol. 347, http://dx.doi.org/10.1136/bmj.f5680
2013
Palmer SC; Di Micco L; Razavian M; Craig JC; Perkovic V; Pellegrini F; Jardine MJ; Webster AC; Zoungas S; Strippoli GFM, 2013, 'Antiplatelet agents for chronic kidney disease.', Cochrane database of systematic reviews (Online), vol. 2
2013
Wang AY; Ivany JN; Perkovic V; Gallagher MP; Jardine MJ, 2013, 'Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: Systematic review and meta-analysis of randomized, controlled trials', Nephrology Dialysis Transplantation, vol. 28, pp. 2875 - 2888, http://dx.doi.org/10.1093/ndt/gft406
2013
Levin A; Perkovic V, 2013, 'Epidemiology: Global Burden of Disease Study 2010: Implications for nephrology', Nature Reviews Nephrology, vol. 9, pp. 195 - 197, http://dx.doi.org/10.1038/nrneph.2013.38
2013
Neuen BL; Taylor GE; Demaio AR; Perkovic V, 2013, 'Global kidney disease', The Lancet, vol. 382, pp. 1243, http://dx.doi.org/10.1016/S0140-6736(13)62086-3
2013
Badve SV; Beller EM; Cass A; Francis DP; Hawley C; Macdougall IC; Perkovic V; Johnson DW, 2013, 'Interventions for erythropoietin-resistant anaemia in dialysis patients', Cochrane Database of Systematic Reviews, vol. 2013, http://dx.doi.org/10.1002/14651858.CD006861.pub3
2013
Sindone A; Erlich J; Perkovic V; Suranyi M; Newman H; Lee C; Barin E; Roger SD, 2013, 'ACEIs for cardiovascular risk reduction: Have we taken our eye off the ball?', Australian Family Physician, vol. 42, pp. 634 - 638
2013
Perkovic V; Heerspink HL; Chalmers J; Woodward M; Jun M; Li Q; Macmahon S; Cooper ME; Hamet P; Marre M; Mogensen CE; Poulter N; Mancia G; Cass A; Patel A; Zoungas S, 2013, 'Intensive glucose control improves kidney outcomes in patients with type 2 diabetes', Kidney International, vol. 83, pp. 517 - 523, http://dx.doi.org/10.1038/ki.2012.401
2013
Lv J; Ehteshami P; Sarnak MJ; Tighiouart H; Jun M; Ninomiya T; Foote C; Rodgers A; Zhang H; Wang H; Strippoli GFM; Perkovic V, 2013, 'Effects of intensive blood pressure lowering on the progression of chronic kidney disease: A systematic review and meta-analysis', CMAJ, vol. 185, pp. 949 - 957, http://dx.doi.org/10.1503/cmaj.121468
2013
Sindone A; Erlich J; Perkovic V; Suranyi M; Newman H; Lee C; Barin E; Roger SD, 2013, 'ACEIs for cardiovascular risk reduction Have we taken our eye off the ball?', AUSTRALIAN FAMILY PHYSICIAN, vol. 42, pp. 634 - 638, http://search.informit.com.au/documentSummary;dn=537302915216331;res=IELHEA
2013
Palmer SC; Di Micco L; Razavian M; Craig JC; Ravani P; Perkovic V; Tognoni G; Graziano G; Jardine M; Pellegrini F; Nicolucci A; Webster A; Strippoli GFM, 2013, 'Antiplatelet therapy to prevent hemodialysis vascular access failure: Systematic review and meta-analysis', American Journal of Kidney Diseases, vol. 61, pp. 112 - 122, http://dx.doi.org/10.1053/j.ajkd.2012.08.031
2013
Wang AY; Ivany JN; Perkovic V; Gallagher MP; Jardine MJ, 2013, 'Erratum: Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: Systematic review and meta-analysis of randomized, controlled trials (Nephrology Dialysis Transplantation (2013) 28:11 (2875-2888) DOI: 10.1093/ndt/gft406)', Nephrology Dialysis Transplantation, vol. 28, pp. 3127, http://dx.doi.org/10.1093/ndt/gft501
2013
Zhu B; Wang Y; Jardine M; Jun M; Lv JC; Cass A; Liyanage T; Chen HY; Wang YJ; Perkovic V, 2013, 'Tripterygium preparations for the treatment of CKD: A systematic review and meta-analysis', American Journal of Kidney Diseases, vol. 62, pp. 515 - 530, http://dx.doi.org/10.1053/j.ajkd.2013.02.374
2013
Mooney JF; Ranasinghe I; Chow CK; Perkovic V; Barzi F; Zoungas S; Holzmann MJ; Welten GM; Biancari F; Wu VC; Tan TC; Cass A; Hillis GS, 2013, 'Preoperative estimates of glomerular filtration rate as predictors of outcome after surgery: A systematic review and meta-analysis', Anesthesiology, vol. 118, pp. 809 - 824, http://dx.doi.org/10.1097/ALN.0b013e318287b72c
2013
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Nigwekar SU; Hegbrant J; Strippoli GFM, 2013, 'HMG CoA reductase inhibitors (statins) for dialysis patients', Cochrane Database of Systematic Reviews, vol. 2013, http://dx.doi.org/10.1002/14651858.CD004289.pub5
2013
Jun M; Jardine MJ; Gray N; Masterson R; Kerr PG; Agar JWM; Hawley CM; Van Eps C; Cass A; Gallagher M; Perkovic V, 2013, 'Outcomes of extended-hours hemodialysis performed predominantly at home', American Journal of Kidney Diseases, vol. 61, pp. 247 - 253, http://dx.doi.org/10.1053/j.ajkd.2012.08.032
2013
Kotwal S; Jun M; Sullivan D; Perkovic V; Neal B, 2012, 'Omega 3 fatty acids and cardiovascular outcomes: Systematic review and meta-analysis', Circulation: Cardiovascular Quality and Outcomes, vol. 5, pp. 808 - 818, http://dx.doi.org/10.1161/CIRCOUTCOMES.112.966168
2012
Jun M; Zhu B; Tonelli M; Jardine MJ; Patel A; Neal B; Liyanage T; Keech A; Cass A; Perkovic V, 2012, 'Effects of fibrates in kidney disease: A systematic review and meta-analysis', Journal of the American College of Cardiology, vol. 60, pp. 2061 - 2071, http://dx.doi.org/10.1016/j.jacc.2012.07.049
2012
Palmer SC; Micco LD; Razavian M; Craig JC; Perkovic V; Pellegrini F; Copetti M; Graziano G; Tognoni G; Jardine M; Webster A; Nicolucci A; Zoungas S; Strippoli GFM, 2012, 'Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease:A systematic review and meta-analysis', Annals of Internal Medicine, vol. 156, pp. 445 - 459, http://dx.doi.org/10.7326/0003-4819-156-6-201203200-00007
2012
Jun M; Venkataraman V; Razavian M; Cooper B; Zoungas S; Ninomiya T; Webster A; Perkovic V, 2012, 'Antioxidants for chronic kidney disease', Cochrane Database of Systematic Reviews, vol. 18, pp. 576 - 578, http://dx.doi.org/10.1111/nep.12103
2012
Becker GJ; Wheeler DC; De Zeeuw D; Fujita T; Furth SL; Holdaas H; Mendis S; Oparil S; Perkovic V; Saad Rodrigues CI; Sarnak MJ; Schernthaner G; Tomson CRV; Zoccali C, 2012, 'Kidney disease: Improving global outcomes (KDIGO) blood pressure work group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease', Kidney International Supplements, vol. 2, pp. 337 - 414, http://dx.doi.org/10.1038/kisup.2012.46
2012
Wong G; Zoungas S; Lo S; Chalmers J; Cass A; Neal B; Woodward M; Perkovic V; Glasziou P; Williams B; Howard K; Chapman JR; Craig JC, 2012, 'The risk of cancer in people with diabetes and chronic kidney disease', Nephrology Dialysis Transplantation, vol. 27, pp. 3337 - 3344, http://dx.doi.org/10.1093/ndt/gfs022
2012
Hillis GS; Hata J; Woodward M; Perkovic V; Arima H; Chow CK; Zoungas S; Patel A; Poulter NR; Mancia G; Williams B; Chalmers J, 2012, 'Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitus.', Journal of the American Heart Association, vol. 1, http://dx.doi.org/10.1161/JAHA.112.002832
2012
Lv J; Perkovic V; Foote CV; Craig ME; Craig JC; Strippoli GFM, 2012, 'Antihypertensive agents for preventing diabetic kidney disease', Cochrane Database of Systematic Reviews, vol. 2012, http://dx.doi.org/10.1002/14651858.CD004136.pub3
2012
Razavian M; Heeley EL; Perkovic V; Zoungas S; Weekes A; Patel AA; Anderson CS; Chalmers JP; Cass A, 2012, 'Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study)', Nephrology Dialysis Transplantation, vol. 27, pp. 1396 - 1402, http://dx.doi.org/10.1093/ndt/gfr599
2012
Jardine MJ; Hata J; Woodward M; Perkovic V; Ninomiya T; Arima H; Zoungas S; Cass A; Patel A; Marre M; Mancia G; Mogensen CE; Poulter N; Chalmers J, 2012, 'Prediction of kidney-related outcomes in patients with type 2 diabetes', American Journal of Kidney Diseases, vol. 60, pp. 770 - 778, http://dx.doi.org/10.1053/j.ajkd.2012.04.025
2012
Perkovic V; Patil V; Wei L; Lv J; Petersen M; Patel A, 2012, 'Global randomized trials: The promise of India and China', Journal of Bone and Joint Surgery - Series A, vol. 94, pp. 92 - 96, http://dx.doi.org/10.2106/JBJS.L.00274
2012
Toussaint ND; Pedagogos E; Tan SJ; Badve SV; Hawley CM; Perkovic V; Elder GJ, 2012, 'Phosphate in early chronic kidney disease: Associations with clinical outcomes and a target to reduce cardiovascular risk', Nephrology, vol. 17, pp. 433 - 444, http://dx.doi.org/10.1111/j.1440-1797.2012.01618.x
2012
Jardine MJ; Kang A; Zoungas S; Navaneethan SD; Ninomiya T; Nigwekar SU; Gallagher MP; Cass A; Strippoli G; Perkovic V, 2012, 'The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: Systematic review and meta-analysis', BMJ (Online), vol. 344, http://dx.doi.org/10.1136/bmj.e3533
2012
Foote C; Ninomiya T; Gallagher M; Perkovic V; Cass A; McDonald SP; Jardine M, 2012, 'Survival of elderly dialysis patients is predicted by both patient and practice characteristics', Nephrology Dialysis Transplantation, vol. 27, pp. 3581 - 3587, http://dx.doi.org/10.1093/ndt/gfs096
2012
Jun M; Venkataraman V; Razavian M; Cooper B; Zoungas S; Ninomiya T; Webster AC; Perkovic V, 2012, 'Antioxidants for chronic kidney disease', Cochrane Database of Systematic Reviews, vol. 2012, http://dx.doi.org/10.1002/14651858.CD008176.pub2
2012
Zhu B; Jun M; Jardine MJ; Wang YJ; Perkovic V, 2012, 'Haemodialysis duration, frequency and intensity for endstage kidney disease (Protocol)', Cochrane Database of Systematic Reviews, http://dx.doi.org/10.1002/14651858.CD010064
2012
Perkovic V; Neal B, 2012, 'Trials in kidney disease - Time to EVOLVE', New England Journal of Medicine, vol. 367, pp. 2541 - 2542, http://dx.doi.org/10.1056/NEJMe1212368
2012
Jun M; Badve SV; Hawley CM; Pilmore H; White S; Cass A; Perkovic V; Zoungas S, 2012, 'Glucose lowering therapies for chronic kidney disease and kidney transplantation (Protocol)', Cochrane Database of Systematic Reviews, http://dx.doi.org/10.1002/14651858.CD009966
2012
Lv J; Neal B; Ehteshami P; Ninomiya T; Woodward M; Rodgers A; Wang H; MacMahon S; Turnbull F; Hillis G; Chalmers J; Perkovic V, 2012, 'Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis', PLoS Medicine, vol. 9, http://dx.doi.org/10.1371/journal.pmed.1001293
2012
Lv J; Xu D; Perkovic V; Ma X; Johnson DW; Woodward M; Levin A; Zhang H; Wang H, 2012, 'Corticosteroid therapy in IgA nephropathy', Journal of the American Society of Nephrology, vol. 23, pp. 1108 - 1116, http://dx.doi.org/10.1681/ASN.2011111112
2012
Foote C; Perkovic V; Neal B, 2012, 'Effects of SGLT2 inhibitors on cardiovascular outcomes', Diabetes and Vascular Disease Research, vol. 9, pp. 117 - 123, http://dx.doi.org/10.1177/1479164112441190
2012
McMahon LP; Cai MX; Baweja S; Holt SG; Kent AB; Perkovic V; Leikis MJ; Becker GJ, 2012, 'Mortality in dialysis patients may not be associated with ESA dose: A 2-year prospective observational study', BMC Nephrology, vol. 13, http://dx.doi.org/10.1186/1471-2369-13-40
2012
Jun M; Jo J; Perkovic V; Jardine MJ, 2011, 'Managing cardiovascular risk in people with chronic kidney disease: A review of the evidence from randomized controlled trials', Therapeutic Advances in Chronic Disease, vol. 2, pp. 265 - 278, http://dx.doi.org/10.1177/2040622311401775
2011
Zentner D; Hunt D; Chan W; Barzi F; Grigg L; Perkovic V, 2011, 'Prospective evaluation of aortic stenosis in end-stage kidney disease: A more fulminant process?', Nephrology Dialysis Transplantation, vol. 26, pp. 1651 - 1655, http://dx.doi.org/10.1093/ndt/gfq596
2011
Gangadharan komala M; Pianta T; Jardine MJ; Webster A; Perkovic V, 2011, 'Interventions for preventing intradialytic hypotension in haemodialysis patients (Protocol)', The Cohrane Collaboratiion, vol. Issue 12, pp. 1 - 11, http://dx.doi.org/10.1002/14651858.CD009459.pub2
2011
Lambers Heerspink HJ; Perkovic V; De Zeeuw D, 2011, 'Is doubling of serum creatinine a valid clinical 'hard' endpoint in clinical nephrology trials?', Nephron - Clinical Practice, vol. 119, http://dx.doi.org/10.1159/000327614
2011
Huxley RR; Barzi F; Lam TH; Czernichow S; Fang X; Welborn T; Shaw J; Ueshima H; Zimmet P; Jee SH; Patel JV; Caterson I; Perkovic V; Woodward M, 2011, 'Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease: An individual participant data meta-analysis of 23 studies in the asia-pacific region', Circulation, vol. 124, pp. 2056 - 2064, http://dx.doi.org/10.1161/CIRCULATIONAHA.111.028373
2011
Czernichow S; Zanchetti A; Turnbull F; Barzi F; Ninomiya T; Kengne AP; Lambers Heerspink HJ; Perkovic V; Huxley R; Arima H; Patel A; Chalmers J; Woodward M; MacMahon S; Neal B, 2011, 'The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: Meta-analysis of randomized trials', Journal of Hypertension, vol. 29, pp. 4 - 16, http://dx.doi.org/10.1097/HJH.0b013e32834000be
2011
Lv J; Perkovic V, 2011, 'Blood pressure management in diabetes: A path forward?', Journal of Hypertension, vol. 29, pp. 1283 - 1284, http://dx.doi.org/10.1097/HJH.0b013e3283491537
2011
Badve SV; Roberts MA; Hawley CM; Cass A; Garg AX; Krum H; Tonkin A; Perkovic V, 2011, 'Effects of beta-adrenergic antagonists in patients with chronic kidney disease: A systematic review and meta-analysis', Journal of the American College of Cardiology, vol. 58, pp. 1152 - 1161, http://dx.doi.org/10.1016/j.jacc.2011.04.041
2011
Badve SV; Brown F; Hawley CM; Johnson DW; Kanellis J; Rangan GK; Perkovic V, 2011, 'Challenges of conducting a trial of uric-acid-lowering therapy in CKD', Nature Reviews Nephrology, vol. 7, pp. 295 - 300, http://dx.doi.org/10.1038/nrneph.2010.186
2011
Perkovic V; Huxley R, 2011, 'Prognostic value of CRP in stable coronary artery disease unclear due to a variety of biases in existing studies, therefore no clinical practice recommendations can be made', Evidence-Based Medicine, vol. 16, pp. 23 - 24, http://dx.doi.org/10.1136/ebm1143
2011
Maione A; Navaneethan SD; Graziano G; Mitchell R; Johnson D; Mann JFE; Gao P; Craig JC; Tognoni G; Perkovic V; Nicolucci A; De Cosmo S; Sasso A; Lamacchia O; Cignarelli M; Maria Manfreda V; Gentile G; Strippoli GFM, 2011, 'Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro-and macroalbuminuria and other cardiovascular risk factors: A systematic review of randomized controlled trials', Nephrology Dialysis Transplantation, vol. 26, pp. 2827 - 2847, http://dx.doi.org/10.1093/ndt/gfq792
2011
Jun M; Zoungas S; Perkovic V; Webster AC, 2010, 'How to read a report of a randomized controlled trial', Nephrology, vol. 15, pp. 153 - 157, http://dx.doi.org/10.1111/j.1440-1797.2009.01275.x
2010
Tsukamoto Y; Jha V; Becker G; Chen HC; Perkovic V; Prodjosudjadi W; Tungsanga K; Wang H; Morad Z, 2010, 'A challenge to chronic kidney disease in Asia: The report of the second Asian forum of chronic kidney disease initiative', Nephrology, vol. 15, pp. 248 - 252, http://dx.doi.org/10.1111/j.1440-1797.2009.01269.x
2010
Gallagher MP; Kelly PJ; Jardine M; Perkovic V; Cass A; Craig JC; Eris J; Webster AC, 2010, 'Long-term cancer risk of immunosuppressive regimens after kidney transplantation', Journal of the American Society of Nephrology, vol. 21, pp. 852 - 858, http://dx.doi.org/10.1681/ASN.2009101043
2010
Ninomiya T; Zoungas S; Neal B; Woodward M; Patel A; Perkovic V; Cass A; Cooper M; Grobbee D; Hamet P; Harrap S; Liu L; Mancia G; Mogensen CE; Poulter N; Rodgers A; Williams B; MacMahon S; Chalmers J, 2010, 'Efficacy and safety of routine blood pressure lowering in older patients with diabetes: Results from the advance trial', Journal of Hypertension, vol. 28, pp. 1141 - 1149, http://dx.doi.org/10.1097/HJH.0b013e328338a89c
2010
Lambers Heerspink HJ; Ninomiya T; Perkovic V; Woodward M; Zoungas S; Cass A; Cooper M; Grobbee DE; Mancia G; Mogensen CE; Neal B; Chalmers J, 2010, 'Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease', European Heart Journal, vol. 31, pp. 2888 - 2896, http://dx.doi.org/10.1093/eurheartj/ehq139
2010
Baigent C; Landray M; Reith C; Dasgupta T; Emberson J; Herrington W; Lewis D; Mafham M; Collins R; Bray C; Chen Y; Baxter A; Young A; Hill M; Knott C; Cass A; Feldt-Rasmussen B; Fellström B; Grobbee R; Grönhagen-Riska C; Haas M; Holdaas H; Hooi LS; Jiang L; Kasiske B; Krairittichai U; Levin A; Massy Z; Tesar V; Walker R; Wanner C; Wheeler D; Wiecek A; Majoni W; Simpson D; Strony J; Musliner T; Agodoa L; Armitage J; Chen Z; Craig J; De Zeeuw D; Gaziano M; Grimm R; Krane V; Neal B; Ophascharoensuk V; Pedersen T; Sleight P; Tobert J; Tomson C; Sandercock P; Keech A; Whelton P; Yusuf S; Peto R; Parish S; Dolph L; Bahu T; Booth-Davey E; Brewster A; Yau F; Denis E; Frederick K; Haywood D; Heineman J; Howard S; Jayne K; Madgwick Z; Michell S; Murphy K; Ning L; Nolan J; Nunn M; Roberts J; Wickman M; Bowman L; Bulbulia R; Haynes R; Rahimi K; Rahman N; Ait-Sadi R; Barton I; Zhu W; Clark S; Kourellias K; Radley M; Brown K; Worthing D; Coates G; Goodenough B; Lucas N; Carreras A; Currie R; Donaldson O; Fjalling E; Gallagher M; Gibson K; Goddard J; Healy J, 2010, 'Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease', American Heart Journal, vol. 160, pp. 785 - 794, http://dx.doi.org/10.1016/j.ahj.2010.08.012
2010
Perkovic V; Jun M; Neal B, 2010, 'Authors' reply', The Lancet, vol. 376, pp. 1051 - 1052, http://dx.doi.org/10.1016/S0140-6736(10)61482-1
2010
Perkovic V; Cass A, 2010, 'Glomerular filtration rate and the risk of stroke', BMJ (Online), vol. 341, pp. 739, http://dx.doi.org/10.1136/bmj.c4390
2010
Jun M; Foote C; Lv J; Neal B; Patel A; Nicholls SJ; Grobbee DE; Cass A; Chalmers J; Perkovic V, 2010, 'Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis', The Lancet, vol. 375, pp. 1875 - 1884, http://dx.doi.org/10.1016/S0140-6736(10)60656-3
2010
Jun M; Lambers Heerspink HJ; Ninomiya T; Gallagher M; Bellomo R; Myburgh J; Finfer S; Palevsky PM; Kellum JA; Perkovic V; Cass A, 2010, 'Intensities of renal replacement therapy in acute kidney injury: A systematic review and meta-analysis', Clinical Journal of the American Society of Nephrology, vol. 5, pp. 956 - 963, http://dx.doi.org/10.2215/CJN.09111209
2010
Jardine MJ; Ninomiya T; Perkovic V; Cass A; Turnbull F; Gallagher MP; Zoungas S; Lambers Heerspink HJ; Chalmers J; Zanchetti A, 2010, 'Aspirin is beneficial in hypertensive patients with chronic kidney disease: A post-hoc subgroup analysis of a randomized controlled trial', Journal of the American College of Cardiology, vol. 56, pp. 956 - 965, http://dx.doi.org/10.1016/j.jacc.2010.02.068
2010
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Tonelli M; Garg AX; Pellegrini F; Ravani P; Jardine M; Perkovic V; Graziano G; McGee R; Nicolucci A; Tognoni G; Strippoli GFM, 2010, 'Meta-analysis: Erythropoiesis-stimulating agents in patients with chronic kidney disease', Annals of Internal Medicine, vol. 153, pp. 23 - 33, http://dx.doi.org/10.7326/0003-4819-153-1-201007060-00252
2010
O'Seaghdha CM; Perkovic V; Lam TH; McGinn S; Barzi F; Gu DF; Cass A; Suh I; Muntner P; Giles GG; Ueshima H; Woodward M; Huxley R, 2009, 'Blood pressure is a major risk factor for renal death: An analysis of 560 352 participants from the asia-pacific region', Hypertension, vol. 54, pp. 509 - 515, http://dx.doi.org/10.1161/HYPERTENSIONAHA.108.128413
2009
Nigwekar SU; Cass A; Gallagher MP; Jardine MJ; Kang A; Kulshrestha S; Navaneethan SD; Perkovic V; Strippoli GFM; Zoungas S, 2009, 'Interventions for lowering plasma homocysteine levels in dialysis patients', Cochrane Database of Systematic Reviews, http://dx.doi.org/10.1002/14651858.CD004683.pub3
2009
Zoungas S; De Galan BE; Ninomiya T; Grobbee D; Hamet P; Heller S; MacMahon S; Marre M; Neal B; Patel A; Woodward M; Chalmers J, 2009, 'Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial', Diabetes Care, vol. 32, pp. 2068 - 2074, http://dx.doi.org/10.2337/dc09-0959
2009
Huxley R; Clifton P; Perkovic V; Woodward M; Neal B, 2009, 'How many Australian deaths from heart disease and stroke could be avoided by a small reduction in population cholesterol levels?', Nutrition and Dietetics, vol. 66, pp. 158 - 163, http://dx.doi.org/10.1111/j.1747-0080.2009.01360.x
2009
Hu J; Jiang X; Li N; Yu X; Perkovic V; Chen B; Zhao L; Neal B; Wu Y, 2009, 'Effects of salt substitute on pulse wave analysis among individuals at high cardiovascular risk in rural China: A randomized controlled trial', Hypertension Research, vol. 32, pp. 282 - 288, http://dx.doi.org/10.1038/hr.2009.7
2009
Huxley R; Lee CMY; Barzi F; Timmermeister L; Czernichow S; Perkovic V; Grobbee DE; Batty D; Woodward M, 2009, 'Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: A systematic review with meta-analysis', Archives of Internal Medicine, vol. 169, pp. 2053 - 2063, http://dx.doi.org/10.1001/archinternmed.2009.439
2009
De Galan BE; Perkovic V; Ninomiya T; Pillai A; Patel A; Cass A; Neal B; Poulter N; Harrap S; Mogensen CE; Cooper M; Marre M; Williams B; Hamet P; Mancia G; Woodward M; Glasziou P; Grobbee DE; MacMahon S; Chalmers J, 2009, 'Lowering blood pressure reduces renal events in type 2 diabetes', Journal of the American Society of Nephrology, vol. 20, pp. 883 - 892, http://dx.doi.org/10.1681/ASN.2008070667
2009
Ninomiya T; Perkovic V; Verdon C; Barzi F; Cass A; Gallagher M; Jardine M; Anderson C; Chalmers J; Craig JC; Huxley R, 2009, 'Proteinuria and Stroke: A Meta-analysis of Cohort Studies', American Journal of Kidney Diseases, vol. 53, pp. 417 - 425, http://dx.doi.org/10.1053/j.ajkd.2008.08.032
2009
Ninomiya T; Perkovic V; De Galan BE; Zoungas S; Pillai A; Jardine M; Patel A; Cass A; Neal B; Poulter N; Mogensen CE; Cooper M; Marre M; Williams B; Hamet P; Mancia G; Woodward M; MacMahon S; Chalmers J, 2009, 'Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes', Journal of the American Society of Nephrology, vol. 20, pp. 1813 - 1821, http://dx.doi.org/10.1681/ASN.2008121270
2009
Navaneethan SD; Nigwekar SU; Perkovic V; Johnson DW; Craig JC; Strippoli GF, 2009, 'HMG CoA reductase inhibitors (statins) for dialysis patients.', Cochrane database of systematic reviews (Online)
2009
Navaneethan SD; Perkovic V; Johnson DW; Nigwekar SU; Craig JC; Strippoli GFM, 2009, 'HMG CoA reductase inhibitors (statins) for kidney transplant recipients.', Cochrane database of systematic reviews (Online)
2009
White SL; Perkovic V; Cass A; Chang CL; Poulter NR; Spector T; Haysom L; Craig JC; Salmi IA; Chadban SJ; Huxley RR, 2009, 'Is Low Birth Weight an Antecedent of CKD in Later Life? A Systematic Review of Observational Studies', American Journal of Kidney Diseases, vol. 54, pp. 248 - 261, http://dx.doi.org/10.1053/j.ajkd.2008.12.042
2009
Navaneethan SD; Pansini F; Perkovic V; Manno C; Pellegrini F; Johnson DW; Craig JC; Strippoli GFM, 2009, 'HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.', Cochrane database of systematic reviews (Online)
2009
Navaneethan SD; Nigwekar SU; Perkovic V; Johnson DW; Craig JC; Strippoli GFM, 2009, 'HMG CoA reductase inhibitors (statins) for dialysis patients', Cochrane Database of Systematic Reviews, http://dx.doi.org/10.1002/14651858.CD004289.pub4
2009
Perkovic V; Heerspink HL; Ninomiya T; Cass A; Neal B, 2009, 'Blood pressure in dialysis patients-look before we leap - Authors' reply', The Lancet, vol. 373, pp. 1945 - 1946, http://dx.doi.org/10.1016/S0140-6736(09)61062-X
2009
Zoungas S; Ninomiya T; Huxley R; Cass A; Jardine M; Gallagher M; Patel A; Vasheghani-Farahani A; Sadigh G; Perkovic V, 2009, 'Systematic review: Sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy', Annals of Internal Medicine, vol. 151, pp. 631 - 638, http://dx.doi.org/10.1059/0003-4819-151-9-200911030-00008
2009
Joshi R; de Galan BE; Chalmers J; Perkovic V; Patel A, 2009, 'Routine blood pressure lowering and intensive glucose control in patiens with type 2 diabetes: The ADVANCE trial', Expert Review of Endocrinology and Metabolism, vol. 4, pp. 111 - 118, http://dx.doi.org/10.1586/17446651.4.2.111
2009
Navaneethan SD; Perkovic V; Johnson DW; Nigwekar SU; Craig JC; Strippoli GFM, 2009, 'HMG CoA reductase inhibitors (statins) for kidney transplant recipients', Cochrane Database of Systematic Reviews, http://dx.doi.org/10.1002/14651858.CD005019.pub3
2009
Navaneethan SD; Pansini F; Perkovic V; Manno C; Pellegrini F; Johnson DW; Craig JC; Strippoli GFM, 2009, 'HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis', Cochrane Database of Systematic Reviews, http://dx.doi.org/10.1002/14651858.CD007784
2009
Kang A; Nigwekar SU; Perkovic V; Kulshrestha S; Zoungas S; Navaneethan SD; Cass A; Gallagher MP; Ninomiya T; Strippoli GFM; Jardine MJ, 2009, 'Interventions for lowering plasma homocysteine levels in kidney transplant recipients', Cochrane Database of Systematic Reviews, http://dx.doi.org/10.1002/14651858.CD007910
2009
Lambers Heerspink HJ; Perkovic V; De Zeeuw D, 2009, 'Renal and cardio-protective effects of direct renin inhibition: A systematic literature review', Journal of Hypertension, vol. 27, pp. 2321 - 2331, http://dx.doi.org/10.1097/HJH.0b013e3283310f92
2009
Heerspink HJL; Ninomiya T; Zoungas S; de Zeeuw D; Grobbee DE; Jardine MJ; Gallagher M; Roberts MA; Cass A; Neal B; Perkovic V, 2009, 'Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials', The Lancet, vol. 373, pp. 1009 - 1015, http://dx.doi.org/10.1016/S0140-6736(09)60212-9
2009
Gallagher M; Jardine M; Perkovic V; Cass A; McDonald S; Petrie J; Eris J, 2009, 'Cyclosporine withdrawal improves long-term graft survival in renal transplantation', Transplantation, vol. 87, pp. 1877 - 1883, http://dx.doi.org/10.1097/TP.0b013e3181a76823
2009
Perkovic V; Cass A; Patel AA; Suriyawongpaisal P; Barzi F; Chadban S; MacMahon S; Neal B, 2008, 'High prevalence of chronic kidney disease in Thailand', Kidney International, vol. 73, pp. 473 - 479, http://dx.doi.org/10.1038/sj.ki.5002701
2008
Strippoli GFM; Navaneethan SD; Johnson DW; Perkovic V; Pellegrini F; Nicolucci A; Craig JC, 2008, 'Effects of statins in patients with chronic kidney disease: Meta-analysis and meta-regression of randomised controlled trials', BMJ, vol. 336, pp. 645 - 651, http://dx.doi.org/10.1136/bmj.39472.580984.AE
2008
Turnbull F, 2008, 'Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger people: Meta-analysis of randomised trials', BMJ, vol. 336, pp. 1121 - 1123, http://dx.doi.org/10.1136/bmj.39548.738368.BE
2008
White SL; McGeechan K; Jones M; Cass A; Chadban SJ; Polkinghorne KR; Perkovic V; Roderick PJ, 2008, 'Socioeconomic disadvantage and kidney disease in the United States, Australia, and Thailand', American Journal of Public Health, vol. 98, pp. 1306 - 1313, http://dx.doi.org/10.2105/AJPH.2007.116020
2008
Perkovic V; Verdon C; Ninomiya T; Barzi F; Cass A; Patel A; Jardine M; Gallagher M; Turnbull F; Chalmers J; Craig J; Huxley R, 2008, 'The relationship between proteinuria and coronary risk: A systematic review and meta-analysis', PLoS Medicine, vol. 5, pp. 1486 - 1495, http://dx.doi.org/10.1371/journal.pmed.0050207
2008
Turnbull F; Woodward M; Neal B; Barzi F; Ninomiya T; Chalmers J; Perkovic V; Li N; MacMahon S; Agodoa L; Anderson C; Asselbergs FW; Baigent C; Black H; Brenner B; Brown M; Bulpitt C; Byington R; Collins R; Cutler J; Dahlof B; Davis B; De Zeeuw D; Dens J; Estacio R; Fagard R; Fox K; Fukui T; Hansson L; Holman R; Hunsicker L; Imai Y; Ishii M; Kanno Y; Kostis J; Kuramoto K; Lewis E; Lièvre M; Lindholm LH; Liu L; Lubsen J; Lueders S; Malacco E; Mancia G; Matsuzaki M; Ohkubo T; Ogihara T; Palmer C; Pepine C; Pfeffer M; Pitt B; Poole-Wilson P; Poulter N; Rahman M; Remme W; Remuzzi G; Rodgers A; Ruggenenti P; Saruta T; Schrader J; Schrier R; Sever P; Sleight P; Staessen J; Suzuki H; Teo K; Van Gilst WH; Viberti G; Wang J; Whelton P; Wing L; Yui Y; Yusuf S; Zanchetti A, 2008, 'Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials', European Heart Journal, vol. 29, pp. 2669 - 2680, http://dx.doi.org/10.1093/eurheartj/ehn427
2008
Ninomiya T; Perkovic V; Gallagher M; Jardine M; Cass A; Arima H; Anderson C; Neal B; Woodward M; Omae T; MacMahon S; Chalmers J, 2008, 'Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial', Kidney International, vol. 73, pp. 963 - 970, http://dx.doi.org/10.1038/ki.2008.5
2008
Agodoa L; Anderson C; Asseibergs F; Baigent C; Black H; Brenner B; Brown M; Bulpitt C; Byington R; Chalmers J; Collins R; Cutler J; Dahlof B; Davis B; De Zeeuw D; Dens J; Estacio R; Fagard R; Fox K; Fukui T; Hansson L; Holman R; Hunsicker L; Imai Y; Ishii M; Kanno Y; Kostis J; Kuramoto K; Lewis E; Lièvre M; Lindholm LH; Liu L; Lubsen J; Lueders S; MacMahon S; Malacco E; Mancia G; Matsuzaki M; Neal B; Nissen S; Ohkubo T; Ogihara T; Pepine C; Pfeffer M; Pitt B; Poole-Wilson P; Rahman M; Remme W; Remuzzi G; Rodgers A; Ruggenenti P; Saruta T; Schrader J; Schrier R; Sever P; Sleight P; Staessen J; Teo K; Viberti G; Wang J; Whelton P; Wing L; Yui Y; Yusuf S; Zanchetti A; Turnbull F; Pfeffer M; Kostis J; Algert C; Woodward M; Chalmers J; Zanchetti A, 2007, 'Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system', Journal of Hypertension, vol. 25, pp. 951 - 958, http://dx.doi.org/10.1097/HJH.0b013e3280bad9b4
2007
Perkovic V; Ninomiya T; Arima H; Gallagher M; Jardine M; Cass A; Neal B; MacMahon S; Chalmers J, 2007, 'Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: Data from the PROGRESS study', Journal of the American Society of Nephrology, vol. 18, pp. 2766 - 2772, http://dx.doi.org/10.1681/ASN.2007020256
2007
Chalmers J; Kengne AP; Joshi R; Perkovic V; Patel A, 2007, 'New insights from ADVANCE.', Journal of hypertension. Supplement : official journal of the International Society of Hypertension, vol. 25 Suppl 1, http://dx.doi.org/10.1097/01.hjh.0000271506.69949.46
2007
Glasziou P; Alexander J; Beller E; Clarke P; Chalmers J; MacMahon S; Cooper M; Ferrannini E; Grobbee D; Hamet P; Harrap S; Heller S; Lisheng L; Mancia G; Marre M; Mogensen C; Neal B; Yu Pan C; Patel A; Poulter N; Rodgers A; William B; Woodward M; Collins R; Holman R; Sleight P; Adams M; Branley M; Fulcher G; Jenkins B; Louis D; Lou W; Lowe H; McCormack A; Mitchell P; Ong S; Pollock C; Watson J; Wong T; Allen S; Bompoint S; Carreras A; Chen T; Flynn S; Gibbo S; Han D; Hough S; Jayne K; Joshi R; Kengne AP; Linn J; Monaghan H; Ng R; Perkovic V; Regaglia J; Schmidt M; Xin D; Yufang B; Holloway T; Gray B; Milne A; Adderkin A; Guertin MR; de Guise D; Liyuan M; Reid J; Subramaniam R; Wen W; Williamson K, 2007, 'Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial', Health and Quality of Life Outcomes, vol. 5, http://dx.doi.org/10.1186/1477-7525-5-21
2007
Perkovic V; Huxley R; Wu Y; Prabhakaran D; MacMahon S, 2007, 'The burden of blood pressure-related disease: A neglected priority for global health', Hypertension, vol. 50, pp. 991 - 997, http://dx.doi.org/10.1161/HYPERTENSIONAHA.107.095497
2007
Gallagher M; Perkovic V; Chalmers J, 2006, 'Diuretics: A modern day treatment option? (Review article)', Nephrology, vol. 11, pp. 419 - 427, http://dx.doi.org/10.1111/j.1440-1797.2006.00598.x
2006
Suranyi MG, 2006, 'ADVANCE: lessons from the run-in phase of a large study in type 2 diabetes.', Blood Pressure, vol. 15, pp. 340 - 346, http://dx.doi.org/10.1080/08037050601066074
2006
Chalmers J; Perkovic V; Joshi RC; Patel A, 2006, 'ADVANCE : breaking new ground in type 2 diabetes', Journal of Hypertension (Supplement), vol. 24, pp. S22 - S28, http://dx.doi.org/10.1097/01.hjh.0000240043.50838.28
2006
Chalmers J; Perkovic V; Joshi R; Patel A, 2006, 'ADVANCE: Breaking new ground in type 2 diabetes', Journal of Hypertension, vol. 24, http://dx.doi.org/10.1097/01.hjh.0000240043.50838.28
2006
Kerr P; Perkovic V; Petrie J; Agar J; Disney A, 2005, 'The CARI guidelines. Dialysis adequacy (HD) guidelines.', Nephrology (Carlton, Vic.), vol. 10 Suppl 4
2005
Packham DK; Perkovic V; Savige J; Broome MRA, 2005, 'Hematuria in thin basement membrane nephropathy', Seminars in Nephrology, vol. 25, pp. 146 - 148, http://dx.doi.org/10.1016/j.semnephrol.2005.01.005
2005
Perkovic V; Hewitson TD; Kelynack KJ; Martic M; Tait MG; Becker GJ, 2003, 'Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells', Kidney and Blood Pressure Research, vol. 26, pp. 27 - 33, http://dx.doi.org/10.1159/000069761
2003
Perkovic V; Hunt D; Griffin SV; du Plessis M; Becker GJ, 2003, 'Accelerated progression of calcific aortic stenosis in dialysis patients.', Nephron. Clinical practice, vol. 94
2003
Perkovic V; Thomson KR; Becker GJ, 2002, 'Factors affecting outcome after percutaneous renal artery stent insertion', Journal of Nephrology, vol. 15, pp. 649 - 654
2002
Becker GJ; Perkovic V; Hewitson TD, 2001, 'Pharmacological intervention in renal fibrosis and vascular sclerosis', Journal of Nephrology, vol. 14, pp. 332 - 339
2001
Perkovic V; Thomson KR; Mitchell PJ; Gibson RN; Atkinson N; Field PL; Becker GJ, 2001, 'Treatment of renovascular disease with percutaneous stent insertion: Long-term outcomes', Australasian Radiology, vol. 45, pp. 438 - 443, http://dx.doi.org/10.1046/j.1440-1673.2001.00953.x
2001
Perkovic V; Came NA; Grigg AP; Becker GJ, 1999, 'Haemolytic uraemic syndrome and prostatic cancer', Australian and New Zealand Journal of Medicine, vol. 29, pp. 383 - 384, http://dx.doi.org/10.1111/j.1445-5994.1999.tb00730.x
1999
Conference Abstracts
add
Perkovic V; Bain S; Bakris G; Buse J; Gondolf T; Idorn T; Lausvig N; Mahaffey K; Marso S; Nauck M; Pratley R; Rossing P; Zinman B; Mann J, 2019, 'EGFR LOSS WITH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUE TREATMENT: DATA FROM SUSTAIN 6 AND LEADER', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, Budapest, HUNGARY, Vol. 34, presented at 56th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA) - Burden, Access and Disparities in Kidney Disease, Budapest, HUNGARY, 13 June 2019 - 16 June 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000495412900567&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Perkovic V; Bain S; Bakris G; Buse J; Idorn T; Mahaffey K; Marso S; Nauck M; Pratley R; Rasmussen S; Rossing P; Tornoe K; Zinman B; Mann J, 2019, 'EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUES SEMAGLUTIDE AND LIRAGLUTIDE ON RENAL OUTCOMES - A POOLED ANALYSIS OF THE SUSTAIN 6 AND LEADER TRIALS', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, Budapest, HUNGARY, Vol. 34, pp. 338 - 338, presented at 56th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA) - Burden, Access and Disparities in Kidney Disease, Budapest, HUNGARY, 13 June 2019 - 16 June 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000495412901136&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Perkovic V; Bain SC; Bakris G; Buse JB; Gondolf T; Idorn T; Lausvig N; Mahaffey K; Marso SP; Nauck MA; Pratley R; Rossing P; Zinman B; Mann J, 2019, 'Estimated GFR (eGFR) loss with glucagon-like peptide-1 (GLP-1) analogue treatment: data from SUSTAIN 6 and LEADER', in DIABETOLOGIA, SPRINGER, Barcelona, SPAIN, Vol. 62, pp. S484 - S485, presented at 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Barcelona, SPAIN, 16 September 2019 - 20 September 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485303804096&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Perkovic V; Bain S; Bakris G; Buse J; Idorn T; Mahaffey K; Marso S; Nauck M; Pratley R; Rasmussen S; Rossing P; Tornoe K; Zinman B; Mann J, 2019, 'EFFECTS OF SEMAGLUTIDE AND LIRAGLUTIDE ON URINARY ALBUMIN-TO-CREATININE RATIO (UACR) - A POOLED ANALYSIS OF SUSTAIN 6 AND LEADER', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, Budapest, HUNGARY, Vol. 34, pp. 205 - U715, presented at 56th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA) - Burden, Access and Disparities in Kidney Disease, Budapest, HUNGARY, 13 June 2019 - 16 June 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000495412900568&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Neuen BL; Perkovic V; Ohkuma T; Neal B; Matthews DR; de Zeeuw D; Mahaffey KW; Fulcher G; Oh R; Li Q; Jardine M, 2019, 'Canagliflozin in patients with type 2 diabetes and macroalbuminuria: data from the CANVAS program', in DIABETOLOGIA, SPRINGER, Barcelona, SPAIN, Vol. 62, pp. S341 - S342, presented at 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Barcelona, SPAIN, 16 September 2019 - 20 September 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485303803041&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Oshima M; Ohkuma T; Neal B; Li Q; De Zeeuw D; Mahaffey KW; Fulcher G; Canovatchel W; Matthews DR; Perkovic V, 2019, 'DIFFERENT EGFR THRESHOLDS AND THE RENAL EFFECTS OF CANAGLIFLOZIN: DATA FROM THE CANVAS PROGRAM', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, Budapest, HUNGARY, Vol. 34, pp. 206 - 206, presented at 56th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA) - Burden, Access and Disparities in Kidney Disease, Budapest, HUNGARY, 13 June 2019 - 16 June 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000495412900569&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Mahaffey KW; Li J; Badve SV; Zhou Z; Oh R; Lee M; Perkovic V; de Zeeuw D; Fulcher G; Matthews DR; Neal B, 2019, 'The effects of canagliflozin on uric acid and gout in patients with type 2 diabetes in the CANVAS programme', in DIABETOLOGIA, SPRINGER, Barcelona, SPAIN, Vol. 62, pp. S340 - S341, presented at 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Barcelona, SPAIN, 16 September 2019 - 20 September 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485303803039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Neal B; Li J; Perkovic V; Woodward M; Figtree GA; Heerspink HL; Mahaffey KW; de Zeeuw D; Vercruysse F; Shaw W; Matthews DR, 2019, 'An exploration of factors mediating the effects of canagliflozin on heart failure in patients with type 2 diabetes', in DIABETOLOGIA, SPRINGER, Barcelona, SPAIN, Vol. 62, pp. S343 - S343, presented at 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Barcelona, SPAIN, 16 September 2019 - 20 September 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485303803044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Haber A; Smyth B; Trongtrakul K; Talbot B; Hawley C; Perkovic V; Woodward M; Jardine M, 2018, 'RELATIVE CONTRIBUTIONS TO MAJOR DIALYSIS RANDOMISED CONTROLLED TRIALS FROM TEN GLOBAL REGIONS', in NEPHROLOGY, WILEY, Vol. 23, pp. 29 - 29, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700065&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Perkovic V; Neuen BL; Ohkuma T; Neal B; Matthews DR; de Zeeuw D; Mahaffey KW; Fulcher G; Desai M; Li Q; Deng H; Rosenthal N; Bakris G, 2018, 'CANAGLIFLOZIN AND RENAL OUTCOMES IN PATIENTS WITH CHRONIC KIDNEY DISEASE', in AMERICAN JOURNAL OF KIDNEY DISEASES, W B SAUNDERS CO-ELSEVIER INC, Austin, TX, Vol. 71, pp. 574 - 574, presented at Spring Clinical Meeting of the National-Kidney Foundation (NKD), Austin, TX, 10 April 2018 - 14 April 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000428167100243&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Smyth B; Van den Broek-Best O; Hong D; Howard K; Rogers K; Gray N; De Zoysa JR; Chan CT; Lin H; Zheng L; Xu J; Cass A; Gallagher M; Perkovic V; Jardine M, 2018, 'THE QUALITY OF LIFE IMPROVEMENTS ASSOCIATED WITH EXTENDED HOURS DIALYSIS ARE CONSISTENT ACROSS SUBGROUPS', in NEPHROLOGY, WILEY, Vol. 23, pp. 28 - 28, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Smyth B; Howard K; Zuo L; De Zoysa J; Chan C; Gray N; Cass A; Gallagher M; Perkovic V; Jardine M, 2018, 'IMPACT OF EXTENDED HOURS DIALYSIS ON UTILITY-BASED QUALITY OF LIFE: RESULTS FROM THE ACTIVE DIALYSIS TRIAL', in NEPHROLOGY, WILEY, Vol. 23, pp. 11 - 12, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Smyth B; Chan C; Grieve S; Puranik R; Zuo L; Hong D; Gray N; De Zoysa J; Scaria A; Gallagher M; Perkovic V; Jardine M, 2018, 'FACTORS ASSOCIATED WITH REGRESSION OF LEFT VENTRICULAR MASS INDEX IN THE ACTIVE DIALYSIS TRIAL', in NEPHROLOGY, WILEY, Vol. 23, pp. 28 - 28, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Book Chapters
add
Rahimi K; Perkovic V, 2018, 'Meta-Analyses of Blood Pressure Lowering Trials and the Blood Pressure Lowering Treatment Trialists' Collaboration', in Hypertension: A Companion to Braunwald's Heart Disease, pp. 433 - 441, http://dx.doi.org/10.1016/B978-0-323-42973-3.00047-0
2018
Jun M; Perkovic V, 2015, 'Fibrates: risk-benefits and role in treating dyslipidemias', in Contemporary Endocrinology, Humana Press, pp. 423 - 438, http://dx.doi.org/10.1007/978-1-60761-424-1_25
2015
Wang AY; Jardine M; Perkovic V, 2014, 'Kidney Disease in Diabetes', in Managing Cardiovascular Complications in Diabetes, pp. 58 - 86, http://dx.doi.org/10.1002/9781118337967.ch3
2014
Wang Y; Perkovic V; Jardine M, 2014, 'kidney disease in diabetes', in Managing Cardiovascular Complications in Diabetes, John Wiley & Sons
2014
Jun M; Perkovic V; Cass A, 2011, 'Intensive glycemic control and renal outcome', in Diabetes and the Kidney, Karger Medical and Scientific Publishers, pp. 196 - 208, http://dx.doi.org/10.1159/000325664
2011